the pharmaconomists’ pension fund - din pension pka · the pension fund offers an average...

65
The Pharmaconomists’ Pension Fund Adopted at the General Meeting of the Pension Fund on 24 April 2019 Chairman of the Meeting

Upload: others

Post on 17-Jun-2020

8 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

The Pharmaconomists’

Pension Fund

Adopted at the General Meeting of the Pension Fund on 24 April 2019

Chairman of the Meeting

Page 2: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

2 Annual Report 2018

Contents

Management Review 3

Management Statement 10

The independent auditor’s report 11

Income Statemente and Total Income Statement 15

Balance Sheet 16

Equity and Capital Base 18

Notes 19

Page 3: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

3 Annual Report 2018

Management Review The Pharmaconomists’ Pension Fund carries out pension fund activities. The Pension Fund accepts pharma-conomists as members; they are entitled and obliged to membership of the Pension Fund through their

collective labour market agreement or contract of employment. In addition, the Board of Directors may accept members working in similar positions and with a corresponding educational background. The Pension Fund has organised its activities in the form of investment activities in affiliated companies. However, the results obtained by the Pension Fund Group as a whole decide a member’s pension entitle-ment. The key figures in this report are thus given at Group level, unless otherwise specified.

Result for the year The Group’s result for 2018 amounted to a loss of DKK 55.1 mill. The Board of Directors proposes to carry forward the loss to next year. Members’ contributions, excluding deposits, and pension payments increased. However, the Pension Fund

is not growing, since pension disbursements exceed pension contributions.

The total return before the pension return tax on the Pension Fund’s assets was -2.4%. The result for the year is deemed to be acceptable and the Pension Fund remains well-consolidated. The year under review

Economy The global economies continued on an upbeat note in 2018, registering growth of around 4 %. This growth was supported by a decline in unemployment both in the US and in Europe. At the same time, inflation went up and gave rise to a tightening of monetary policy by central banks in the US and Europe. The US saw four interest rate increases in 2018, while the European Central Bank decided to stop buying bonds after December 2018.

Uncertainty as to how the tighter monetary policy and the threat of a global trade war will affect global

growth gave rise to a fall in share markets in the US and Europe in Q4, when the markets fell by 14% and 12%, respectively. For 2018 as a whole, the decline was 6% in the US and 14% in Europe. These falls in share markets put a damper on interest increases, since many investors went for safer in-vestments, such as bonds. In Europe, interest rates were largely unchanged in 2018, while the US 10-year

rate went up by approx. 0.3 %. This is lower than the short interest rates, which increased by 1% in line with the interest rate increases carried out by the Federal Reserve. Account interest rate The Pension Fund’s account interest rate was 4.7% before tax. Again in 2019, the account interest rate has been set at 4.7% before tax.

Investment portfolio Return The total return in 2018 was -2.4%, corresponding to DKK -254.7 mill.

Bonds and tangible assets contributed positive returns in 2018, while shares, credit and absolute return

generated negative returns.

Page 4: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

4 Annual Report 2018

Investments and social responsibility On the basis of the UN millennium goals and the Paris climate agreement, the Pension Fund focuses strongly on combating climate change, disseminating green energy and promoting sustainability. The mil-lennium goals are hallmarks for the Pension Fund’s climate strategy. In addition, the Pension Fund’s guidelines for responsible investments are in line with the principles of the

UN Global Compact. As an addition to the UN Global Compact, the Pension Fund has adopted a policy of not investing in controversial weapons, coalmines or tobacco. Furthermore, the Pension Fund has a tax policy. Active ownership is exercised primarily by entering into a dialogue with the companies in which invest-ments are made, so as to ensure that they comply with the guidelines laid down by the Pension Fund. The

purpose is to ensure the long-term value creation of these companies, which also generates the highest possible returns to the members of the Pension Fund. If a company does not live up to the guidelines, the Pension Fund enters into a dialogue with the company concerned. If there are no prospects of the company improving in the longer term, and if the company continues to act against the interests of the Pension

Fund, the company will be excluded from the Pension Fund’s investment universe. Excluded companies are registered and published on the Pension Fund’s website; the website also contains information about com-panies on the observation list and companies with which we have entered into a dialogue.

Based on financial and climate-related considerations, the Pension Fund decided in 2015 to discontinue its investments in the first coalmine companies. Since then, the Pension Fund has entered into a dialogue with quite many companies with activities in coal. The purpose of this dialogue is to reduce the companies’ ac-tivities in coal and convert to more climate-friendly sources of energy. This has resulted in the Pension Fund excluding 60 companies, while there is an ongoing dialogue with 7 companies.

There is also a focus on oil and gas companies and whether their business models are in accordance with the climate objective laid down in the Paris agreement. On the same basis as coalmine companies, 63 oil and gas companies have been excluded, while there is an ongoing dialogue with 19 companies. The obser-vation list is updated on an ongoing basis. Towards the end of the year under review, the Pension Fund started focusing on the transport sector, in-

cluding the car sector in particular. A dialogue has been started with 15 companies; these companies make

up a total of 3/4 of the Pension Fund’s total investments in the car sector. In early 2019, these companies will be assessed in the light of green conversion, including the Paris agreement goals. The Pension Fund also uses its ownership to promote workers’ rights – here, too, general meetings are used as a lever to promote responsible behaviour. PKA is convinced that companies, employees and inves-tors benefit from decent wages and working conditions. That is why PKA is working to help companies un-

derstand that investments in decent wages and working conditions contribute towards a company’s long-term value creation. In 2018, the Pension Fund had a dialogue with 38 companies about the rights of their workers. In cooperation with the other pension funds in the PKA cooperation structure, the Pension Fund has an ambitious goal, saying that 10% of net assets, corresponding to DKK 30 billion all in all, is to be invested in climate projects by the end of 2020, against a total of DKK 21 billion at the end of 2018. In 2019, the

focus will thus be on making investments that create value at different levels. Naturally, these will be cli-mate investments in particular, but there is also a focus on making investments in developing countries, where Maj Invest is in charge of launching the company’s third micro-financing fund, and where the Pen-

sion Fund has participated in the two previous ones. Cooperation on investments and cash flow

The Pension Fund’s assets are managed by PKA A/S and, based on an agreement, the Pension Fund coop-erates with other pension funds administered by PKA A/S on effective and rational management of its in-vestments and cash flow, so as to obtain the highest possible return and the lowest possible costs. Derivative financial instruments The Pension Fund makes use of derivate financial instruments for investment and hedging purposes.

Page 5: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

5 Annual Report 2018

Risks and solvency associated with the Pension Fund’s business model The Pension Fund’s business model rests on a labour-market-agreement-based, collective, solidarity-based labour market pension scheme. The most significant risks are market risks, insurance-related risks and outsourcing risks.

Market risks The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent, just as the Pension Fund has a small number of members with 4.5% interest. This involves interest risk exposure, which is hedged on an ongoing basis. The Pension Fund wishes to deliver robust pensions to its members. This is ensured through a long-term

investment strategy, whose aim is to achieve high, stable returns in a responsible way; as a minimum, these investments must be able to meet the return requirement from the converted pensions. Long-term low returns on investment assets or major financial losses constitute a risk when it comes to delivering robust pensions. This exposure is the Pension Fund’s market risk. This risk is mitigated by spreading in-

vestments to cover a wide range of different asset classes. Investments are made collectively for members. Any losses on investments are covered collectively and

the share of bonus potentials in the Pension Fund ensures that any losses on the financial markets are not charged to members’ deposits in individual years, but that instead members receive the account in-terest announced at any given time on their deposits – at present 4.7% before tax. The Pension Fund carries out ongoing monitoring of conversion risks. Risk-taking is a precondition for achieving an adequate return that will guarantee robust pensions. In this connection, the Board of Directors has a major task in deciding on the Pension Fund’s risk appetite in the

form of a chosen investment strategy. The Pension Fund’s risk appetite is decided on the basis of two goals. The Pension Fund protects the members’ pensions in the Risk Management Model, and the Pension Fund complies with all applicable solvency rules (SCR). In its risk management policy, the Board of Directors decides the safety levels for the Rism Management Model that provide the risk framework for the Pension Fund when it comes to pro-

tecting pensions. Furthermore, in special cases, solvency cover may provide a framework for the risk-

taking of the Pension Fund. The Pension Fund has a capital plan and an emergency plan based on the Risk Management Model and the solvency capital requirement (SCR). In the capital plan, the financial situation in the Pension Fund’s strategic planning period is deemed to be reassuring.

Insurance risks The Pension Fund provides life-long pensions. Most of the pledges have been given on a conditional basis, which means that the size of pensions is linked to conditions rgarding interest rates, life expectancy, and the risk of disablement. A conditional basis gives the Pension Fund the possibility to reduce parameters in the technical basis, in which cases pensions will also be reduced. The Pension Fund is a solidarity-based scheme with disablement cover without any required health infor-

mation upon admission, as long as the member is in one of the job groups that are comprised The Pension Fund monitors developments in its insurance risks closely and makes provisions in accord-ance with the life expectancy benchmark laid down by the Danish FSA.

Outsourcing The Pension Fund uses outsourcing to a considerable extent. Direct outsourcing goes to PKA A/S, which

in turn has outsourced much of operations on to Forca A/S. The administration of real property invest-ments has been outsourced to DEAS A/S. Risk is managed in the form of controls and service delivery agreements.

Page 6: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

6 Annual Report 2018

Capitel Equity was reduced in 2018 by DKK 55.1 mill. to DKK 1,245.7 mill. The capital base is now DKK 1,652.3 mill. against DKK 1,723.3 mill. in 2017. The SCR solvency requirement has been calculated using the standard model. As at 1 January 2018, SCR was calculated to be DKK 537.0 mill. while at the end of 2018 it amounted to DKK 492.9 mill.

The solvency cover key ratio as a percentage is only calculated for the Pension Fund, and no key ratios are prepared for the group, since the group covers only one pension fund. The solvency cover as a percentage over the last five years is given in the table below.

2014 2015 2016 2017 2018

Solvency cover in % 482 514 326 321 335 The Financial Statements Order was change with effect from 2016. It has not been deemed practically possible to change the figures for the period before 2016 to streamline them with the new method. Consequently, the figures for 2014-2015 are not directly comparable with 2016-2018.

The Pension Fund has chosen to use the possibility of giving sensitivity information in the Management Review, not as a note in the Financial Statements; this applies from the 2018 Annual Report onwards. The sensitivity analysis is given in the Pension Fund’s solvency and financial conditioning report (SFCR) 2018, which is available on the following website: www.PKA.dk.

Bonus policy The determination of interest rates is based on the objection of ensuring stable development of members’ pensions over time. The Board of Directors has fixed the account interest rate at 4.7% for 2019. The account interest rate may be reduced if required for financial reasons. Other rates are basically determined once a year.

The Pension Fund equity is owned by the members. The full result obtained by the Pension Fund always accrues to its members.

Superannuation provisions Provisions for pension agreements consist of the elements Guaranteed disbursements, Individual bonus potential, Collective bonus potential, and Risk margin.

Provisions for pension agreement were reduced in 2018 by DKK 408.9 mill. to DKK 8,546.5 mill. Uncertainty of recognition and measurement When the Annual Report is prepared, a number of estimates and assessments of future aspects are made; these have an influence on the accounting value of assets and commitments.

The most significant areas concern pension obligations and the valuation of unlisted, alternative invest-ments. Management finds that the assumptions made are responsible, but associated with uncertainty. The accounting estimates are described in more detail in note 1”Accounting Policies”.

Page 7: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

7 Annual Report 2018

Events after the Balance Sheet date No events after the Balance Sheet date have any significant influence on the financial standing of the Pen-sion Fund or the Group. Expectations regarding the future The global economy still shows no noteworthy signs of weakness; unemployment is low in the US and Eu-

rope alike, just as inflation is at a satisfactory level of around 2%. Most recently, economic indicators in the US and Europe showed a declining trend, probably because of the threat of a global trade war. It is still early days, when it comes to assessing whether this is a sign of a long-term weakening of the economy. Until there is more clarity about the economic development, it is to be expected that the financial markets remain nervous; additional falls in interest rates and share prices in 2019 cannot be excluded.

Uncertainty about global growth will also influence the frequency of interest rate increases carried out by the US Federal Reserve. Such increases are expected to be fewer than the four seen in 2018. In Europe, interest rate increases are not expected until Q4 at the earliest, because of uncertainty about economic

developments. The Pension Fund is robust and well-prepared for such challenges.

Administration The Pension Fund and the affiliated companies are administered by PKA A/S. PKA A/S has outsourced some of its administrative tasks, e.g. to Forca A/S and PKA AIP A/S. The Executive Management and the appointed Actuary are employed by, but not paid by, the Pension Fund.

The Pension Fund Group The Pension Fund’s affiliated (wholly owned) companies as at 31 December 2018 can be seen from the Group chart.

The Pharmaconomists’

Pension Fund

The Pharmaconomists’ Property Company (plc)

FarmaPension A/S

The Pension Fund’s Property Company (plc) The purpose of the company is to own and operation real property, so as to obtain a long-term return on the invested capital. The company’s result for 2018 was a profit of DKK 2.4 mill.

FarmaPension A/S The company has no activities. The company has submitted a request for repayment of wrongly collected VAT for a past period. The Danish tax authorities have not yet started processing the request. The result for 2018 is 0.0 mill. Audit Committee

In accordance with legislation, the Pension Fund must establish an Audit Committee. The chairman must be independent and at least one member must have qualifications in accounting or auditing. The chairman of the Audit Committee is Susanne Kure, who meets the requirements both for independ-ence and for qualifications in accounting or auditing. The other member of the Audit Committee is Su-sanne Engstrøm.

Page 8: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

8 Annual Report 2018

Progress report on compliance with the goal regarding the underrepresented gender at man-agement level The Financial Services Act requires that financial companies must set a target for gender representation on the board of directors and prepare a policy on equal representation if one gender is underrepresented on the Board. Such underrepresentation exists if either gender has less than 40% of the Board members.

The rules of setting a target for gender representation on the board of directors are based on the board members elected by the general meeting; however, in the Pension Fund, the majority of board members are appointed by social partners concluding labour market agreements. That is why it will not be correct to adopt a target for the board members elected by the general meeting; consequently, the board has adopt-ed a target for the gender composition of the board of directors as a whole.

The board has decided that the target for men on the board of directors is to be at least 25 %, while the target for women on the board is to be at least 40 %. At the end of the year under review, the split on the board of directors was 37.5% men and 62.5% women on the board of directors.

The targets have thus been met.

No policy has been adopted regarding equal representation in the management layers below the Execu-tive Management of the Pension Fund. The Pension Fund is fully administered by PKA A/S. In 2018, the gender split of PKA A/S was 57 % men and 43& women in the management layers below the Executive Management. As from 1 December 2018, the gender split changed to become 64% men and 36% wom-en; in the course of 2019, a policy for equal representation in the management layers below the Execu-tive Management of PKA A/S will be prepared.

Page 9: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

9 Annual Report 2018

Other management/board positions

The members of Management hold the following other management/board positions:

Managing Director Peter Damgaard Jensen Man. Dir. of PKA A/S Man. Dir. of PKA+ Pension Forsikringsselskab A/S

Man. Dir. of fire pensionskasser administreret af PKA A/S Man. Dir. of Sundhedsfagliges Ejendomsaktieselskab Man. Dir. of Socialrådgivernes, Socialpædagogernes og Kontorpersonalets Ejendomsaktieselskab Manager of PKA Private Funds GP ApS Manager of PKA Ejendomme af 2012 I/S Chairman of the Board of A/S Kjøbenhavns Ejendomsselskab

Chairman of the Board of Forstædernes Ejendomsaktieselskab Chairman of the Board of Institutional Holding P/S Chairman of the Board of PKA AIP A/S

Chairman of the Board of PKA Private Funds P/S Chairman of the Board of Poppelstykket 12 A/S Chairman of the Board of PKA Skejby Komplementar ApS Chairman of the Board of PKA Skejby P/S

Chairman of the Board of Farmapension A/S Vice-chairman of the Board of Forca A/S Member of the Board of AIP Management P/S Member of the Board of Valified ApS Member of the Board of Forsikringsorganisationernes Fællessekretariat F.M.B.A.

The members of the Board of Directors hold the following other management/board positions:

Chairman of the Board Henrik Klitmøller Rasmussen

Bestyrelsesformand i Gemeinschaft A/S Member of the Board of MP Pension – Pensionskassen for Magistre og Psykologer Member of the Board of MP Ejendomme P/S

Member of the Board of MP Investment Management A/S Vice-chairman Christina Nicolajsen Durinck

Member of the Board of Pensionskassernes Administration A/S Board member Jørgen Moestrup Member of the Board of A-Dosispak Komplementar ApS Member of the Board of Danish Pharma Care A/S Member of the Board of A-Apotekets Dosispak P/S Member of the Board of Apotekernes A.M.B.A

Member of the Board of Danmarks Apotekerforenings Jubilæumsfond Board member Jesper Gulev Larsen Chairman of the Board of Pharmakon A/S Member of the Board of D.A. Invest og Udvikling A/S

Board member Susanne Kure, Chairman of the Audit Committee

Board member and Audit Committee Chairman of PKA+ Pension Forsikringsselskab A/S Board member and Audit Committee member of the Social Workers’, Social Pedagogues’ and Office Staff Pension Fund Member of the Board of Investeringsselskabet af 24. februar 2015 A/S Member of the Board of Genan Holding A/S Member of the Board of Changegroup Holding A/S and 1 of the company’s wholly owned subsidiaries

Board member Susanne Engstrøm, member of the Audit Commitee Other Board members have no additional board/management positions.

Page 10: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

10 Annual Report 2018

Management Statement We have today presented the Annual Report for The Pharmaconomists’ Pension Fund for the 1 January – 31 December 2018 financial year.

The Annual Report is submitted in accordance with the Danish Financial Business Act. We find that the consolidated accounts and financial statements give a true and fair view of the Group’s and the Pension Fund’s assets, liabilities and financial position as at 31 December 2018, as well as the result of the Group’s and the Pension Fund’s activities in the 1 January – 31 December 2018 financial

year. We consider that the Management Review gives a true and fair view of developments in the Group’s and the Pension Fund’s activities and financial standing, the result for the year and the Group’s and Pension Fund’s financial position, as well as describing significant risks and uncertainty factors faced by the Group and the Pension Fund.

We recommend that the Annual Report be adopted by the General Meeting. Hellerup, 11 March 2019 Management:

Peter Damgaard Jensen Managing Director

Hellerup, 11 March 2019

Board of Directors:

Henrik Klitmøller Rasmussen Christina Nicolajsen Durinck Chairman Vice-chairman

Lise Wieweg Rosendahl Hermansen Ann-Mari Damholt Grønbæk

Jesper Gulev Larsen Susanne Engstrøm

Jørgen Moestrup Susanne Kure

Page 11: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

11 Annual Report 2018

The independent auditor’s report To the members of the Pharmaconomists’ Pension Fund

Opinion

In our opinion, the Consolidated Accounts and Financial Statements give a fair view of the Group’s and the Pension Fund’s assets, liabilities and financial position as at 31 December 2018, as well as of the result of the Group’s and Pension Fund’s activities in the 1 January – 31 December 2018 financial year in accord-ance with the Danish Financial Business Act. Our opinion is in line with our long-form audit report to the Audit Committee and the Board of Directors.

What have we audited The Consolidated Accounts and Financial Statements of the Pharmaconomists’ Pension Fund for the finan-cial year from 1 January – 31 December 2018, comprising the Income Statement and Total Income State-

ment, the Balance Sheet, the Equity Statement and Notes, including Accounting Policies (’the Financial Statements’).

Basis for our opinion We have carried out our audit in accordance with international audit standards (ISA) and the additional requirements in force in Denmark. Our responsibility according to these standards and requirements is described in more detail in the section of this auditor’s report entitled The auditor’s responsibility for the audit of the financial statements. We find that the audit proof we have secured is adequate and suitable as a basis for our opinion.

Independence We are independent of the Group in accordance with international ethical rules for auditors (IESBA’s Ethical Rules) and the additional requirements in force in Denmark, just as we are in compliance with our other ethical commitments i accordance with IESBA’s Ethical Rules. In our best conviction, no prohibited non-audit services, as specified i Article 5 (1) of Regulation (EU) No.

537/2014, have been performed. Appointment We were first appointed as the auditor for the Pharmaconomists’ Pension Fund at the General Meeting on 17 April 2018 for the 2018 financial year.

Central aspects of the audit Central aspects of the audit are the aspects which, in our professional assessment, were the most signifi-cant ones in our audit of the 2018 Financial Statements. We dealt with these aspects as part of our audit of the Financial Statements as a whole and the wording of our opinion on the said audit. We offer no separate opinion on these aspects.

Central aspects of the audit How we have processed the central aspects in the audit

Measuring of unlisted investments

Unlisted investments consist of invetments made

indirectly via funds and of direct ownership. These investments have been made primarily in geared loans, disaster insurance, as well as business prop-erties and residential properties. To a minor extent, investments have been made in forestry & farming, as well as private equity.

Investments form part of the account item entitled Investment properties, Investments in affiliated and associated companies, and Other financial in-vestment activities. Directly owned, unlisted investments are measured at an estimated current value, primarily based on

valuation models and assumptions, including Man-

Measuring of unlisted investments

We reviewed and assessed procedures and internal

controls for measuring unlisted investments. We assessed and tested the valuation models used by Management. We tested by sampling the connection between the assumptions used and the calculation of current

values. In addition, we tested prices reported by external managers, just as we carried out internal follow-up on prices and market development. We challenged Management estimates used for calculating current values; we did this based on our knowledge of the portfolio and the market devel-

opment.

Page 12: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

12 Annual Report 2018

agement estimates, which are not observable for third parties. Unlisted investments owned indirectly through

funds and associations and administered externally and measured at an estimated current value based on reports from investment managers, supplemen-tary information about price developments, and analyses of valuations. We focused on measuring unlisted investments,

because the calculation is complex and involves considerable Management estimates. Reference is made to the mention in Consolidated Accounts and Financial Statements of ’Accounting

estimates’ in note 1, ’Investment properties’ in note 8, ’Shares in associated companies’ in note 15, and

’Other financial investment activities’ in note 9.

Measuring of provisions for pension agreements

and investment contracts The Pension Fund has provisions for pension agreements and investment contracts totalling DKK 88,547 mill., which is 77.4% of total provisions. Provisions consist primarily of pension provisions

towards guaranteed payments, individual bonus potential, and risk margin.

The calculation is based on actuary principles and involves significant accounting estimates linked to the actuary assumptions regarding the timing and scope of future payments to policyholders.

The actuary assumptions cover, most significantly, the interest graph for discounting, life expectancies, mortality, disablement, buy-back probability and costs. We focused on measuring provisions for pen-sion agreements and investment contracts, because

the calculation of these provisions is complex and involves considerable accounting estimates. Reference is made to the mention in the Consoli-dated Accounts and Financial Statements regarding ’Accounting estimates’ in note 1, as well as ’Pension

provisions’ in note 13.

Measuring of provisions for pension agreements

and investment contracts We reviewed and assessed the Pension Fund’s pro-cedures and internal controls established in order to ensure that provisions for pension agreements and investment contracts are measured correctly.

In connection with the audit, we used our own ac-tuaries to assess the actuary models and assump-

tions used by the Pension Fund, as well as the cal-culations made, including future payment flows. We assessed and challenged the most significant actuary assumptions, such as the interest graph for

discounting, life expectancies, mortality, disable-ment, buy-back probability and costs based on our experience and knowledge of the industry, so as to be able to assess whether these assumptions are in accordance with market practices as well as regula-tory and accounting-related requirements. This

work included an assessment of the continuity of the basis for calculating provisions.

Page 13: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

13 Annual Report 2018

Statement regarding the Management Review Management is responsible for the Management Review.

Our opinion about the Financial Statements does not cover the Management Review and we express no opinion with any certainty on the Management Review.

When we carry out our audit of the Financial Statements, it is our responsibility to read the Management Review and, in this connection, to consider whether the Management Review is significantly inconsistent with the Financial Statements or seems to contain material misstatements given the knowledge we have

obtained in our audit or in any other way.

Furthermore, our responsibility includes considering whether the Management Review contains the re-quired information as specified in the Danish Financial Business Act.

Based on our work, we find that the Management Review is in accordance with the Financial Statements and has been prepared in accordance with the requirements of the Danish Financial Business Act. We have found no material misstatements in the Management Review.

Management’s responsibility for the Financial Statements

Management is responsible for preparing and presenting Consolidated Accounts and Financial Statements that give a true and fair view in accordance with the Danish Financial Business Act. Furthermore, Man-agement is responsible for the internal controls which Management deems to be necessary for the prepa-ration of Financial Statements without material misstatements regardless of whether such misstatements are the result of fraud or error.

When preparing the Financial Statements, Management is responsible for assessing the ability of the Group and the Pension Fund to continue operations, for giving information about matters regarding con-

tinued operation, where this is relevant, and for preparing the Financial Statements on the basis of the accounting principles for a going concern, unless Management either intends to liquidate the Group or the Pension Fund or discontinue operations, or has no other realistic alternative than to do so.

The auditor’s responsibility for the audit of the Consolidated Accounts and Financial Statements Our aim is to achieve a high degree of certainty that the Financial Statements as a whole are free of mate-rial misstatements, regardless of whether such misstatements are the result of fraud or error, and to pre-

pare an audit report with our opinion. A high degree of certainty means a high level of certainty, but in-volves no guarantee that an audit carried out in accordance with international auditing standards and the additional requirements in Denmark will always discover material misstatements if such exist. Misstate-ments may arise as a result of fraud or error and may be considered significant if it is reasonably to be expected that, individually or jointly, they will have an influence on financial decisions made by users of the accounts on the basis of the Financial Statements.

As part of an audit carried out in accordance with international audit standards and the additional require-ments in Denmark, we make professional assessments and maintain a professional scepticism during our

audit. In addition:

We identify and assess the risk of material misstatements in the Financial Statements, regardless of whether such misstatements are the result of fraud or error, and we plan and carry out audit action as a reaction to these risks and achieve audit proof which is adequate and suitable to form the basis of our opinion. The risk of not discovering material misstatements caused by fraud is higher than if mate-rial misstatements are the result of error, since fraud may come from conspiracy, forgery, deliberate

omissions, misguidance or disregard for internal controls.

We obtain an understanding of the internal controls that are relevant to the audit, so as to be able to carry out audit action, which is suitable in the circumstances, but not in order to be able to offer an opinion about the efficiency or effectiveness of the Group’s and the company’s internal controls.

We decide whether the accounting policies applied by Management are suitable, and whether the ac-counting estimates and associated information prepared by Management are reasonable.

We conclude whether Management’s preparation of the Financial Statements on the basis of a going concern accounting principle is suitable and whether, on the basis the audit proof obtained, there is

any significant uncertainty associated with events or matters which may create substantial doubts about the Group’s and the Pension Fund’s ability to continue operations. If we find that significant un-certainty exists, our audit report must give information about this in the Financial Statements or, if such information is not adequate, we must modify our opinion. Our opinions are based on the audit proof obtained up to the date of our audit report. However, future events or matter may mean that the Group and Pension Fund will no longer be able to continue operations.

Page 14: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

14 Annual Report 2018

We assess the overall presentation, structure and contents of the Consolidated Accounts and Financial Statements, including the Notes, and whether the Consolidated Accounts and Financial Statements re-flect the underlying transactions and events in such a way that a fair view is given thereof.

We obtain adequate, suitable audit proof in regard to the financial information in the companies or the business activities of the Group, so as to be able to give an opinion about the Consolidated Accounts. We are responsible for managing, supervising and performing the Group audit. We have sole responsi-

bility for our audit opinion.

We communicate with the Executive Management, for example about the planned scope and timing of the audit, as well as about significant observations during our audit, including any significant deficiencies in regard to internal controls which we may identify during our audit.

We also make a statement to the Executive Management specifying that we have complied with relevant ethical requirements concerning independence and we inform the Executive Management about all rela-tions and other matters which may reasonably be thought to influence our independence and, where rele-vant, we inform about any precautions taken.

Based on the matters communicated to the Executive Management, we decide which matters were the most significant ones in the audit of the Financial Statements for the period concerned and were thus the central aspects in our audit. We describe these aspects in our audit report, unless legislation or other regu-lations excludes such publication, or if in extreme cases we may decide that aspects are not to be commu-nicated in our audit report, because the negative consequences thereof could reasonably be expected to

outweigh the advantages the public interest in such communication.

Copenhagen, 11 March 2019 PricewaterhouseCoopers

State-authorized Audit Partnership Central Business Reg. No. 33 77 12 31

Christian Fredensborg Jakobsen Per Rolf Larssen

State-authorized Public Accountant State-authorized Public Accountant

mne16539 mne24822

Page 15: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

15 Annual Report 2018

Income Statemente and Total Income Statement

All amounts in DKK mill. Pension Fund Consolidated

Note 2018 2017 2018 2017

Gross member contributions 3 199.5 195.1 199.5 195.1

Total member contributions, own account 199.5 195.1 199.5 195.1

Income from affiliated companies 2.4 -1.0

Income from associated companies 37.5 17.4 37.5 17.4

Income from investment properties 0.1 0.1 2.5 -0.9

Interest income and dividend, etc. 61.6 127.0 61.6 127.0

Price adjustments 4 -107.3 608.4 -107.3 608.4

Interest costs -239.1 -0.7 -239.1 -0.7

Administration costs in connection with

investment activities -9.9 -44.9 -9.9 -44.9

Total return on investment -254.7 706.4 -254.7 706.4

Pension return tax 41.9 -101.3 41.9 -101.3

Pension payments -463.3 -418.0 -463.3 -418.0

Total pension payments, own account -463.3 -418.0 -463.3 -418.0

Change to pension provisions, own

acc. 5 408.9 -88.8 408.9 -88.8 Change to profit margin 0.0 0.0 0.0 0.0

Change to surplus capital 15.9 0.0 15.9 0.0

Administration costs -3.3 -9.2 -3.3 -9.2

Pension-related operating costs, own

acc. 6 -3.3 -9.2 -3.3 -9.2

Transferred return on investment 66.1 -130.3 66.1 -130.3

TECHNICAL PENSION RESULT 11.0 153.9 11.0 153.9

Investment return on equity -80.3 99.5 -80.3 99.5

PROFIT BEFORE TAX -69.2 253.4 -69.2 253.4

Pension return tax, equity 14.2 30.8 14.2 30.8

PROFIT FOR THE YEAR -55.1 284.2 -55.1 284.2

OTHER TOTAL INCOME 0.0 0.0 0.0 0.0

TOTAL INCOME FOR THE YEAR -55.1 284.2 -55.1 284.2

Realised profit 7

Profit for the year is transferred to equity.

Page 16: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

16 Annual Report 2018

Balance Sheet

ASSETS

All amounts in DKK mill. Pension Fund Consolidated

Note 2018 2017 2018 2017

Investment properties 8 3.6 3.6 3.6 43.6

Capital investment in affiliated companies 15 43.4 41.0

Capital investment in associated companies15 250.8 213.3 250.8 213.3

Total investment in affiliated and

associated companies 294.1 254.2 250.8 213.3

Capital investment 83.1 8.3 83.1 8.3

Mutual trust investment 4,656.6 10,378.9 4,656.6 10,378.9

Bonds 5,253.5 0.0 5,253.5 0.0

Other loans 270.8 5.1 270.8 5.1

Deposits with credit institutes 93.2 90.3 93.2 90.3

Derivative financial instruments 89.7 0.0 89.7 0.0

Total other financial investment

assets 9 10,446.9 10,482.6 10,446.9 10,482.6

TOTAL INVESTMENT ASSETS 10,744.6 10,740.5 10,701.3 10,739.5

Receivables related to direct pension business with pension savers 0.0 0.4 0.0 0.4

Receivables from affiliated companies 0.1 0.0

Other receivables 0.0 23.5 0.1 23.5

TOTAL RECEIVABLES 0.1 23.9 0.1 23.9 Deferred tax assets 207.0 90.3 207.0 90.3

Cash in hand and at bank 0.1 0.0 44.0 1.3

OTHER ASSETS, TOTAL 207.1 90.3 251.1 91.6

Interest receivable 29.5 0.0 29.5 0.0

Other prepayments and accruals 55.3 36.0 55.3 36.0

TOTAL PREPAYMENTS AND ACCRUALS 84.8 36.0 84.8 36.0

TOTAL ASSETS 11,036.6 10,890.6 11,037.3 10,890.9

Guarantees 10 Contingent asset 11

Page 17: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

17 Annual Report 2018

Balance Sheet

LIABILITIES

All amounts in DKK mill. Pension Fund Consolidated

Note 2018 2017 2018 2017 Profit carried forward 1,245.7 1,300.8 1,245.7 1,300.8

TOTAL EQUITY 1,245.7 1,300.8 1,245.7 1,300.8 Surplus capital 12 406.6 422.5 406.6 422.5

TOTAL SUBORDINATE LOAN CAPITAL 406.6 422.5 406.6 422.5

Pension provisions 13 8,546.5 8,955.3 8,546.5 8,955.3

Profit margin on pension provisions 0.0 0.0 0.0 0.0

TOTAL PR0VISIONS FOR PENSION

AGREEMENTS AND INVESTMENT 8,546.5 8,955.3 8,546.5 8,955.3

Debt concerning financial derivatives 9 176.6 0.0 176.6 0.0

Debt to credit institutes 558.8 0.0 558.8 0.0

Pension return tax payable 71.6 148.8 71.6 148.8

Other debt 30.0 46.8 30.7 47.2

TOTAL DEBT 837.1 195.6 837.7 196.0

PREPAYMENTS AND ACCRUALS 0.7 16.2 0.7 16.2

TOTAL LIABILITIES 11,036.6 10,890.6 11,037.3 10,890.9

Accounting policies 1

Financial highlights and key ratios for

the last five years 2

Contingencies 14

Affiliated and associated parties 15

Risk and risk management 16

Specification of assets and their

return 17

Page 18: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

18 Annual Report 2018

Equity and Capital Base

All amounts in DKK mill.

Pension Fund Consolidated

Equity 2018 2017 2018 2017

Equity as at 1 January 1,300.8 1,439.2 1,300.8 1,439.2

Transferred to excess capital -422.5 -422.5

Transferred from profit distribution -55.1 284.2 -55.1 284.2

Other total income 0.0 0.0 0.0 0.0

Total equity 1,245.7 1,300.8 1,245.7 1,300.8

Pension Fund Consolidated

Capital base 2018 2017 2018 2017

Equity 1,245.7 1,300.8 1,245.7 1,300.8

Surplus capital 406.6 422.5 406.6 422.5

Total capital base 1,652.3 1,723.3 1,652.3 1,723.3

Page 19: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

19 Annual Report 2018

Notes All amounts in DKK mill.

Note 1 Accounting Policies

The Annual Report for the Group and the Pension Fund has been prepared in accordance with the provi-sions of the Danish Financial Business Act and the executive accounting order from the Danish Financial Supervisory Authority on financial reporting from insurance companies and pension funds.

The accounting policies are unchanged from 2017. Minor reclassifications have been made in the Income Statement and the Balance Sheet. The Annual Report is presented in millions of Danish kroner with one decimal. Each figure is rounded off

separately. Consequently, variations may exist between the totals and the sum of the underlying figures.

Principles regarding the distribution of profits and/or losses In accordance with the executive order on the contribution principle, the Pension Fund has notified the Danish Financial Supervisory Authority of its principle for distributing the result of the year under review. The main principle is that the part of the profit obtained in the year under review and allocated to equity

and surplus capital consists of a yield corresponding to the investment return before pension return tax plus a risk return rate of 0.5% for unconditionally guaranteed holdings and 0.2% for conditionally guaran-teed holdings of the average pension provisions. Payments to and from equity are deducted from the share of the profit for the year that goes to equity. Losses covered by equity and surplus capital can be retrieved in the subsequent financial year from the collective bonus potentials if possible The shares transferred from collective bonus potentials in the subse-

quent financial year are reported to the Danish FSA. Consolidated Accounts The Consolidated Accounts comprise the Pension Fund and affiliated companies, where the Pension Fund

has a controlling influence. The Consolidated Accounts are made by combining (consolidating) accounting items with a uniform content in the Pension Fund and the affiliated companies.

In consolidation, intra-Group income and costs are eliminated together with intra-Group share holdings and outstandings. Intra-Group services are charged on market terms or cost-covering terms. Intra-Group trading in securities and other investment assets is charged at market value.

Translation of currencies Transactions in foreign currencies are translated at the exchange rate of the transaction date. Balance Sheet items in foreign currencies are translated at the closing exchange rate of the Balance Sheet date. All currency gains and losses are included in the Income Statement under exchange rate regulation. General principles for recognition and measurement

Assets are recognised in the Balance Sheet if future gains are likely to accrue to the company and the value of the asset can be measured reliably. Commitments are recognised in the Balance Sheet if future gains are likely to be paid by the company and the commitment can be measured reliably. The Income Statement recognises all income as it is earned, while costs are recognised by the amounts that concern the financial year under review.

Purchase and sale of financial instruments are recognised on the transaction date and such recognition ends when the right to receive/pay cash flows from the financial asset or liability has expired, or if it has been assigned. Purchase or sales transactions which had not yet been carried out on the Balance Sheet date are recognised in the Income Statement in the form of their loss or gain. In the first recognition, financial instruments are measured at current value. Measurement after first

recognition is made as described under each accounting item below.

Page 20: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

20 Annual Report 2018

Accounting estimates and uncertainties of recognition and measurement The calculation of the accounting value of certain assets and commitments is made on the basis of meth-ods and with assumptions, which involve the use of accounting estimates. These estimates are made by Management in accordance with the accounting policies defined and on the basis of historical experience and assumptions deemed by Management to be responsible and realistic.

As a result of the nature of these estimates, the assumptions used may turn out to be incomplete, just as unexpected future events or circumstances may arise. This includes the possibility that others may reach other estimates. The most significant estimates made by Management in connection with the calculation of the accounting value of certain assets and commitments, and the significant estimate uncertainty associated with the

preparation of the Financial Statements are the same as in the preparation of the Financial Statements in the previous year. The areas particularly associated with estimates are measuring of the current value of unlisted financial instruments and commitments regarding pension provisions.

The estimates are linked in particular to the assumptions underlying reporting received from external investment managers, as well as the shift in timing from calculation to recognition in the Financial State-ments.

Measuring of the current value of infrastructure assets The valuation of infrastructure assets is based on the current value of the future cash flow during the planning period, projected in internal models. The long planning period – up to 25 years when the in-vestment starts – increases the uncertainty of the expected cash flow. The most significant estimates are linked to the discounting rate of interest, as well as specific elements related to the individual invest-ments, such as the development of electricity prices, production, maintenance costs, and the costs of

disposal when the production period expires. Measuring of the current value of investment properties The determination of the current value of investment properties is associated with significant estimates. Estimates are related in particular to the determination of required returns.

Measuring of the current value of other unlisted financial instruments

The Pension Fund has unlisted investments, where there is no active market. The unlisted investments cover such items as direct investments in unlisted shares, non-registered loans, as well as forestry and agriculture through funds. The calculations are based on models and, to the widest extent possible, on observable data, and the valuations are influenced by estimates. Measuring of pension provisions

Determination of the accounting value of pension provisions is associated with an estimate, especially in regard to the discounting interest rate graph and the assumptions on mortality. The assumptions on the best estimate for disablement are based on the disablement figures observed in recent years. The deter-mination of assumptions is influenced by actuary estimates which are significant to the size of provisions. Income Statement

Gross members’ contributions Gross members’ contribution in the Pension Fund consists of members’ contributions due for January – November as well as expected members’ contributions for December. Members’ contributions have been

reduced by labour market contributions. Return on investment

Income from affiliated and associated companies contains the Pension Fund’s share of the companies’ op-erating results after tax. Income from investment properties consists of the result of property operation before adjustment of prop-erty values. The costs of property administration are deducted from the result. Interest and dividend, etc., include the interest earned and the dividend received, etc., concerning invest-

ment assets in the year under review. Price adjustments consist of realised and unrealised gains on investment assets, including value regulation of investment properties.

Page 21: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

21 Annual Report 2018

Pension return tax Pension return tax is recognised in the Income Statement by an amount calculated on the basis of the taxable return in the year under review. The pension return tax that rests on the return that will only be included in the Pension Fund tax basis in a subsequent financial year is recognised as deferred pension return tax.

Pension return tax is divided between equity and clients. Equity’s share of the pension return tax is calcu-lated on the basis of equity’s share of the result obtained. Pension payments Pension payments consist of processed and paid pensions.

Administration

The Pension Fund pays a fixed annual price (rate) per member to PKA A/S for the agreed administrative services; this amount includes salaries and fees to Management and Board.

In addition, the Pension Fund and the affiliated companies pay a fixed fraction of a percent of the net asset current value to cover portfolio management. The rate and the fraction of a percent are determined on market terms.

The costs of administering securities are recognised as administration costs for investment activities. The costs of property administration are deducted from income from investment property. Transferred return on investment

Transferred return on investment has been calculated on the basis of the pro rata share of the result ob-tained that goes to equity and is included in the equity investment return item. Balance Sheet Assets

Investment properties Investment properties are measured at their value on the Balance Sheet date. Investments in forests are measured at an estimated current value based on a broker’s statement, and the estimated current value of the calculated volume of wood.

A leasure property abroad is measured at acquisition value. Shares in affiliated companies Shares in affiliated companies are measured at intrinsic value (the equity method). Using this method, the operating results of affiliated companies are recognised in the Pension Fund Income Statement. The Pen-sion Fund’s profit and equity are thus identical to those of the Group.

The accounting results from affiliated companies result from using recognition and measurement methods identical to the principles used in the Pension Fund.

Shares in associated companies Shares in associated companies are recognised at the Pension Fund ownership share of the companies’ intrinsic accounting value. The companies’ intrinsic value results from using measurement methods identi-cal to the methods used in the Pension Fund. All regulations are recognised in income from associated

companies. Associated companies are defined as companies that are not affiliated companies, but where the Group’s companies have shares representing more than 20 % of the voting rights, and where considerable influ-ence is exercised over companies’ operational and financial management through representation on the boards of companies.

Associated companies with a negative intrinsic accounting value are measured at zero and any receivables from such companies are impaired by the parent company’s share of the negative intrinsic value to the extent the amount is deemed to be irrecoverable. If the negative intrinsic accounting value exceeds the

Page 22: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

22 Annual Report 2018

amount receivable, the remaining amount is recognised under provisions for commitments to the extent the parent company has a legal or actual commitment to cover the obligations of the company concerned. Shares Listed shares are measured at the value of stock exchange closing prices on the Balance Sheet date.

Unlisted shares is measured at current value based on an individual assessment of the companies with a view to determining the price which such shares are expected to fetch. The valuation is based on infor-mation from external capital managers to a high extent. The Pension Fund has established internal processes to support the estimates prepared. The shift in tim-ing between reporting and accounting data is thus taken into account by obtaining supplementary infor-

mation about price developments. In addition, analyses of valuations are made in relation to external counterparties and in relation to prices determined by an independent financial institution, so as to test and verify the values determined.

Units in mutual trusts Units in mutual trusts are measured at the value of the stock exchange closing prices on the Balance Sheet

date.

Bonds Fixed-interest bonds, convertible bonds and indexed bonds plus index-related adjustments are measured at the value of the stock exchange closing prices on the Balance Sheet date. The current value of drawn bonds is based on the present value of the bonds, which is close to the nominal value of the bonds.

Other lending Direct property credit is measured at current value, which basically is par. The valuation is checked against current spreads in the market, the borrower’s creditworthiness, and the underlying collateral. Other direct credit is measured on the basis of external valuation and checked in relation to developments i similar credit risks for both listed and unlisted securities in the market.

Derivative financial instruments Derivative financial instruments used for interest risk hedging and other purposes are measured at current value. Instruments with a positive current value are recognised as assets under Derivative financial in-struments, while instruments with a negative current value are recognised under Debt related to derivative financial instruments. Repurchase/reversal

Securities sold as part of a sell and buy-back transaction stay on the Balance Sheet under the various main items, e.g. ”bonds” that carry interest and are subject to security price adjustment. The received amount is recognized and carries interest as debt to the other party to the transaction. Securities acquired as part of a purchase and sell-back transaction are recognized as accounts receivable by the other party, while the return is recognised under interest.

Other items under assets Accounts receivable are recognised at face value minus value impairments to cover expected losses.

Liabilities

Equity The Pension Fund’s equity belongs to the members jointly.

Surplus capital Surplus capital forms part of the base capital on equal terms with equity capital, but over time it accrues to the insured and thus forms part of the provision made for insurance contracts.

Provision for pension agreements and investment contracts Provisions for pension agreements and investment contracts are calculated by the Pension Fund Actuary in charge.

As from 30.09.2018 the Pension Fund moved away from using the EIOPAS basic discounting interest graph and started using the EIOPAS discounting interest graph with a VA supplement, when calculating provi-

sions. The interest rates on the interest graph with the VA supplement have not changed much compared

Page 23: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

23 Annual Report 2018

with the end of 2017. Seen in isolation, the changes concerning the interest graph resulted in a decline of DKK 20 mill. in the accumulated value adjustment. The pension provisions consist of the following elements: Guaranteed Payments, Individual Bonus Poten-tial, Collective Bonus Potential and Risk Margin.

The provision element entitled Guaranteed Payments is calculated in that, for each insurance policy, the market value of the expected, guaranteed payment flows is calculated. The market value is calculated by discounting individual payments using the interest rate calculated by EIOPA, the European supervisory authority, plus a Volatility Adjustment supplement and minus the pension return tax. Guaranteed Pay-ments contain an estimated amount to cover future insurance payments stemming from insurance events which occurred during the financial year, but where no claim had yet been filed on the date of the Balance

Sheet. Individual Bonus Potential contains the value of obligations to grant a bonus on the basis of the amount deposited under the individual insurance policy qualifying for the bonus.

Collective Bonus Potential contains the share of the insurance holding of realised results which has been set aside as a collective provision for the insurance policies qualifying for the bonus. This amount has not

yet been ascribed to the individual member. The Risk Margin contains the amount which the Pension Fund must expect to have to pay to another insur-ance company to take over the risk of settling the holding. As far as possible, the Risk Margin is obtained primarily from the Individual Bonus Potential and subsequently form the Collective Bonus Potential – or alternatively from the capital base. The Risk Margin is calculated in accordance with the Solvency II rules. As from 1 January 2018, the Pension Fund changed its method for calculating the risk margin; as from the

2018 financial year, the Pension Fund is using the possibility of applying loss-absorbing buffers. This change has been processed as a change in accounting estimates; seen in isolation, it has reduced the risk margin by DKK 96 mill. The assumptions regarding the best estimate of mortality are based on the FSA benchmark for current mortality, which is adapted to the Pension Fund’s specific situation as regards the observed mortality of the

policy holders. In addition, the FSA benchmark for expected life expectancy improvements is integrated.

The FSA benchmark is updated annually and the Pension Fund carries out an annual analysis of any devia-tions from the benchmark for current mortality.

The assumptions regarding best estimate of disablement are based observed disablement in recent years

The discounting interest graph and the assumptions on mortality are the assumptions which have the highest effect on the measurement of provisions made.

Profit margin The profit margin shows the present value of profit not yet earned by the Pension Fund on insurance poli-cies which are to be recognised in the Income Statement over time. The profit margin is segregated from the pension provisions.

Other items under liabilities Debt is measured at amortised cost, which normally corresponds to the face value. Contingency obligations

Pledges of investments, warranties given, guarantees, etc., outside insurance are listed in a note to the Annual Report. Key ratios Key ratios are prepared in accordance with the rules of the Danish FSA’s executive accounting order on financial reports covering insurance companies and pension funds.

Page 24: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

24 Annual Report 2018

Page 25: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

25 Annual Report 2018

Note 3 Pension Fund Consolidated

Gross member contributions 2018 2017 2018 2017

Direct insurance with bonus scheme

Member contributions 194.2 192.1 194.2 192.1

Member single premiums 5.4 3.0 5.4 3.0

Total gross member contributions 199.5 195.1 199.5 195.1

Pension agreements

Taken out as part of an employee plan 199.5 195.1 199.5 195.1

Premiums divided into countries:

Denmark 198.0 195.1 198.0 195.1

Other EU countries 1.3 0.0 1.3 0.0

Other countries 0.2 0.0 0.2 0.0

Calculation of number of policy holders

Taken out as part of an employee plan 8,132 7,990 8,132 7,990

Note 4 Pension Fund Consolidated

Price adjustments 2018 2017 2018 2017

Capital investment -3.1 -39.2 -3.1 -39.2

Investment fund shares -72.9 288.9 -72.9 288.9

Bonds 114.4 356.6 114.4 356.6

Other loans 3.7 2.3 3.7 2.3

Derivative financial instruments -122.6 0.0 -122.6 0.0

Cash in hand and at bank -26.7 -0.2 -26.7 -0.2

Total price adjustments -107.3 608.4 -107.3 608.4

Note 5 Pension Fund Consolidated

Change to pension provisions, own acc. 2018 2017 2018 2017

Individual bonus potential 157.2 151.0 157.2 151.0

Guaranteed disbursements -460.3 -56.5 -460.3 -56.5

Risk margin -105.8 -5.7 -105.8 -5.7

Total change to pension prov., own acc. -408.9 88.8 -408.9 88.8

All contributions are direct insurance with a

bonus right.

The Pension Fund's total number of insured members has been calculated incl. memberships from which

only spouse and children pensions are paid.

Page 26: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

26 Annual Report 2018

Note 6 Pension Fund Consolidated

Pension-related operating costs, own acc. 2018 2017 2018 2017

261.7 290.0 261.7 290.0

126.3 100.0 126.3 100.0

Susanne Engstrøm 75.3 50.0 75.3 50.0

54.1 50.0 54.1 50.0

54.1 50.0 54.1 50.0

54.1 50.0 54.1 50.0

38.3 38.3

126.3 126.3

130.0 130.0

790.2 720.0 790.2 720.0

Salaries and fees

Pension Fund Consolidated

2018 2017 2018 2017

0.0 6,925.0 0.0 6,925.0

0.0 527.0 0.0 527.0

0.0 43.0 0.0 43.0

0.0 7,495.0 0.0 7,495.0

Auditor

Pension Fund Consolidated

2018 2017 2018 2017

Auditor (amounts in thousands of DKK)

Statutory audit of the Financial Statements 254.0 412.0 254.0 412.0

Other assurance engagements 91.5 75.0 91.5 75.0

Total auditor costs 345.5 487.0 345.5 487.0

The Pension Fund's share of audit costs incl. VAT is:

Lønninger

Jesper Gulev Larsen

Jørgen Moestrup

Lønninger (beløb i tusinde kr.)

The management and the Appointed Actuary are not remunerated by the Pension Fund.

CEO Peter Damgaard Jensen received total remunerations for all his functions from the administration

company, PKA A/S, in the amount of DKK 4,355,000

Total Board fees

Henrik Klitmøller Rasmussen

Samlede lønninger

Lønsumsafgift m.m.

Most of the auditor's work comprises all of the pension funds administered by PKA A/S

Lisa Wieweg Rosendahl Hermansen

Pensionsbidrag

Detailed information about salaries in the administrative company PKA A/S can be read at pka.dk.

Christina Nicolajsen Durick

Ann-Mari Damholt Grønbæk (entered

17.04.2018)

Susanne Kure (entered 01.01.2018)

Bjarne Fabienke (resigned 31.12.2017)

The Pension Fund has no employees other than the management and the Appointed Actuary.

Board fees (amounts in thousands of DKK)

Page 27: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

27 Annual Report 2018

Note 7 Pension Fund Consolidated

Realised profit 2018 2017 2018 2017

-274.0 728.1 -274.0 728.1

-4.2 -25.2 -4.2 -25.2

17.0 6.3 17.0 6.3Market value adjustment 65.4 29.0 65.4 29.0

Total realised profit -195.8 738.0 -195.8 738.0

which is divided into:

Crediting of bonus 345.3 352.6 345.3 352.6

-26.2 132.1 -26.2 132.1

Return for surplus capital -8.7 0.0 -8.7 0.0

Pension return tax concerning surplus

capital -1.6 0.0 -1.6 0.0

Transferred to equity 21.1 284.2 21.1 284.2

-14.2 -30.8 -14.2 -30.8

Ændring i individuel bonuspotentiale -511.6 0.0 -511.6 0.0

Total distribution -195.8 738.0 -195.8 738.0

Movements on equity:

From realised profit 21.1 284.2 21.1 284.2

-51.3 0.0 -51.3 0.0

Profit for the year -30.3 284.2 -30.3 284.2

Missing return, start of year 113.3 240.7 113.3 240.7

-35.8 -127.4 -35.8 -127.4

77.5 113.3 77.5 113.3

Note 8 Pension Fund Consolidated

Investment properties 2018 2017 2018 2017

Current value as at 1 January 3.6 3.6 43.6 48.0

Divestments for the year 0.0 0.0 -40.0 -3.3

0.0 0.0 0.0 -1.1

Total current value 3.6 3.6 3.6 43.6

Transferred to provisions

Pension return tax on return on equity

Realised cost

Pension return tax

Tilgodehavende egenkapitalforrentning

Value impairment

Missing return on equity:

Value adjustment for the year at current value

The principles for distribution of the realised profit and for calculation of risk supplement are described

under accounting policies.

Realised interest

Realised risk

Page 28: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

28 Annual Report 2018

Note 9

Other financial investment assets

Financial instruments (Pension Fund and Consolidated)

Financial derivatives 2018 Yrs to expiry Principal

Book

value

Swaps 0-1 1,950.0 34.8

Swaps 1-10 1,862.5 -7.5

Swaps +10 50.6 -1.8

Forward currency transactions 0-1 10,135.9 -112.5

Note 10 Pension Fund Consolidated

Guarantees 2018 2017 2018 2017

401.7 0.0 401.7 0.0

560.4 0.0 560.4 0.0

Note 11Contingent asset

Guarantees for repurchase agreement

In 2014, Danish VAT procedures were changed; certain services to pension funds are no longer

subject to VAT.

The Pension Fund has submitted an application for repayment of wrongfully collected VAT to the

Danish tax authorities; case processing is pending. It is unclear to which extent the Pension Fund will

achieve such repayment,so the size of the total expected receivable is also uncertain.

Go to www.pka.dk for a continually updated list of the companies in which the Pension Fund has made

capital investments..

As guarantee for compliance with commitments

in hedging interest and share price risks, the

Pension Fund has deposited bonds at a net

value of

The book value of financial derivaties in the Balance Sheet is gross. The sum of all contracts with

positive value is recognised in assets under the item ”Financial derivatives”.The sum of all contracts

with negative value is recognised in liabilities under the item ”Debt relating to financial derivatives”.

The net assets of the Pension Fund are adminestered by PKA A/S.

The Pension Fund's investment policy takes account of a number of social, environmental and ethical

aspects. The Pension Fund does not invest in companies that deliberately and consistently infringe on

national laws or rules laid down by international organisations and adopted by Denmark. Furthermore,

the Pension Fund does not invest in coal mines and companies that manufacture weapons or tobacco.

Derivative financial instruments are linked to significant conditions in regard to the development of

interest rates, share prices and exchange rates.

Other financial instruments, such as bonds, capital investment, etc., are not linked to any special,

significant conditions or terms that could influence future cash flows.

Page 29: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

29 Annual Report 2018

Note 12 Pension Fund ConsolidatedSurplus capital 2018 2017 2018 2017

Surplus capital, start of year 422.5 - 422.5 -

Payments received 10.4 - 10.4 -

Disbursements -17.7 - -17.7 -

-8.7 - -8.7 -Transferred from Equity 422.5 422.5 Total surplus capital 406.6 422.5 406.6 422.5

Note 13 Pension Fund Consolidated

Pension provisions 2018 2017 2018 2017

Pension provisions, start of year 8,955.3 8,866.6 8,955.3 8,866.6

Profit margin, start of year 0.0 0.0 0.0 0.0

Total pension provisions, start of year 8,955.3 8,866.6 8,955.3 8,866.6

Collective bonus potential, start of year 0.0 0.0 0.0 0.0

Accumulated value adj., start of year -272.9 -301.9 -272.9 -301.9

Retrospective provisions, start of year 8,682.4 8,564.7 8,682.4 8,564.7

Gross contribution 199.5 196.8 199.5 196.8

Interest added 342.7 279.8 342.7 279.8

Pension payments -463.3 -411.7 -463.3 -411.7

-3.9 0.0 -3.9 0.0

7.3 12.8 7.3 12.8

51.3 51.1 51.3 51.1

7.3 0.0 7.3 0.0

2.4 -11.1 2.4 -11.1

8,845.2 8,682.4 8,825.7 8,682.4

212.9 272.9 212.9 272.9

Collective bonus potential, end of year 0.0 0.0 0.0 0.0

Total pension provisions, end of year 9,058.1 8,955.3 9,038.6 8,955.3

-511.6 0.0 -511.6 0.0

0.0 0.0 0.0 0.0

Total pension provisions 8,546.5 8,955.3 8,527.0 8,955.3

Individual Collective

Guaranteed bonus- bonus-

payments potential potential Total

Pension provisions as at 1 January 2018

Calculation interest rate 0,0% 5,959.3 2,218.2 0.0 8,177.5

Calculation interest rate 4,5% 577.5 0.6 0.0 578.0

All groups 6,536.8 2,218.8 0.0 8,755.6

Risk margin, all groups 199.8

Total pension provisions 8,955.3

Breakdown of provisions into original base

interest of holdings not comprised by the

contribution principle:

Accumulated value adjustment, end of year

Retrospective provisions, end of year

Profit margin, end of year

The pension fund's insurance is comprised by the contribution principle. However, the pension fund has

adopted other principles for the distribution of profits obtained than what is stated in the Contribution

Order (Order No. 1643 of 14 December 2016). The provisions of the Order are used to the extent they

do not violate the principles of the pension fund. In practice, this means that the pension fund does

not use a group division as stated in Sect. 3 of the Order.

Risk gain after addition of risk bonus

Equity-financed services

Cost supplement after addition of cost bonus

Other

Individual bonus potential applied

Share of realised result after PAL tax

Transferred to/from members' capital

Page 30: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

30 Annual Report 2018

Individual Collective

Guaranteed bonus- bonus-

payments potential potential Total

Pension provisions as at 31 December 2018

Calculation interest rate 0,0% 5,529.1 2,375.4 0.0 7,904.5

Calculation interest rate 4,5% 547.4 0.6 0.0 548.0

All groups 6,076.5 2,376.0 0.0 8,452.5

Risk margin, all groups 93.9

Total pension provisions 8,546.5

2018 2017 2018 2017

Return

percentage

Return

percentage

Bonus

ratio

Bonus

ratio

Calculation interest rate 0,0% -2.4% 6.9% 28.0% 26.6%

Calculation interest rate 4,5% -2.4% 6.9% 0.2% 0.2%

2018 2017

Average interest rate -2.0% 5.0%

Note 14 Pension Fund Consolidated

Contingencies 2018 2017 2018 2017

Investment property 3.6 0.0 3.6 0.0

0.5 0.0 0.5 0.0

250.8 0.0 250.8 0.0

Capital participation 42.0 0.0 42.0 0.0

Unit trust shares 4,438.0 9,720.1 4,438.0 9,720.1

Bonds 4,390.8 0.0 4,390.8 0.0

Secured loans 76.7 0.0 76.7 0.0

Other loans 77.3 0.0 77.3 0.0

Deposits with credit institutes 94.2 84.3 94.2 84.3

Receivable interest 25.0 0.0 25.0 0.0

Total as security for provisions 9,398.8 9,804.4 9,398.8 9,804.4

Investment assets for take-over after

financial year 0.0 0.0 0.0 0.0

Unlisted shares 129.7 6.4 129.7 6.4

Properties 42.6 0.0 42.6 0.0

Infrastructure 26.0 0.0 26.0 0.0

Credit 104.0 0.0 104.0 0.0

302.3 6.4 302.3 6.4

Note 13 continued

As security for insurance-taker provisions, the

following assets have been registered:

Investment pledges after deduction of

amounts already deposited:

Return on customer funds after costs

before tax divided into products:

Return percentage of bonus ratio for

insurance holdings not comprised by the

contribution principle:

Capital participation in affiliated companies

Capital participation in associated companies

Page 31: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

31 Annual Report 2018

Note 14 fortsat

North Sea Infrastructure

Blafa

Zion

In October 2018, PKA acquired 49% of two solar panel parks in California. Both solar parks have been

fully extended and were operational on the acquisition date. The Pension Fund has guarateed its pro

rata share of certain operational and decommisioning-related commitments towards Nordea Bank. The

guarantee commitments amounted to USD 0.8 mill. as per the Balance Sheet date.

In October 2018, the Pension Fund concluded an agreement with Vattenfall and Vestas on the

erection of a 353 MW onshore wind farm in Sweden, near Umeå. The Pension Fund's guarantee

commitment as per the balance Sheet date is the remaining pro rata share of the total investment

pledge plus extra operational guarantees totalling DKK 28.7 mill.

Together with Borgland Advisory AS, the Pension Fund invested in July 2018 in Nyhamna gas

processing plant. This asset is Northwest Norway and forms a central part of the gas infrastructure in

Norway, from where gas from the Norwegian continental shelf is exportd to the UK and to Continental

Europe. As a part of the overall financing, a shareholder loan has been iussued; the residual

commitment on the Balance Sheet date was NOK 1.5 mill. However, the residual commitment is not

expected to be called, as the investment has been fully financed as per the Balance Sheet date.

Note 15

Affiliated and associated parties, etc.

The Pension Fund has

invested capital in the

following affiliated Aktivitet Hjemsted

Ejer-

andel Resultat

Egen-

kapital

Farmakonomernes

Ejendomsaktieselskab

Investment in land and

buildingsGentofte 100.0% 2.4 42.8

Farmapension A/S Administration Copenhagen 100.0% 0.0 0.5

The Pension Fund has

invested capital in the

following associated

companies: Aktivitet Hjemsted

Ejer-

andel Resultat

Egen-

kapital

DEAS Invest I Holding A/S Property administration Frederiksberg 33.3% 43.8 630.6

Page 32: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

32 Annual Report 2018

Note 16

Risk information

A number of risks are associated with the pension fund's business model.

• Life assurance risks

• Market risks, including interest risks

• Outsourcing risk

The Pension Fund uses outsourcing, which gives rise to a focus on the associated risks. There is a risk

of making a loss if agreements or controls are inadequate. The Pension Fund has concluded an

outsourcing agreement with PKA A/S on full administration. The Board has laid down policies and

guidelines for outsourcing significant fields of activity, determining the rules for additional outsourcing

from PKA A/S to a third party. This ensures satisfactory follow-up in regard to the various

subsuppliers, such as Forca A/S.

In connection with its work on risk and solvency, the Board of Directors has identified the major risks

associated with the business model:

As regards life assurance risks, the biometric risks, which comprise life expectancy improvements and

changes to the number of anticipatory pension recipients, constitute the most significant risks. Based

on the Danish FSA’s life expectancy regimen, etc., the Pension Fund has adjusted its assumptions on

life expectancy of its members.

Market risks are defined as the risk that the market value of assets and liabilities will change as a

result of changes to market conditions. The most significant market risks exists in interest rates,

shares foreign exchange and tangible porperty, as well as in investment in alternative sources of yield.

The Pension Fund manages theses risks by ensuring the necessary diversifcation of investments. The

Board has laid down the risk framework for the different classes of assets.

The pension fund hedges against interest risks on guaranteed, deferred pensions based on the Board's

adopted interest risk framework. The consequence of interest hedging is that a significant part of the

interest risk between liabilities and assets has been eliminated. A significant part of the assets for

interest cover are interest swaps, where the Pension Fund pays a variable interest rate and receives a

fixed interest rate. These instruments have the same characteristic as the guaranteed, deferred

pensions in the sense that they increase in value if the interest rate goes down and vice versa.

Note 17

Specification of assets and their return

Primo Ultimo

Land and buildings 44.0 46.4 5.5

Listed capital investments 4,161.1 1,942.9 -2.1

Unlisted capital investments 225.2 499.0 9.4

Total capital investments 4,386.3 2,441.8 0.5

Government- and mortgage credit bonds 3,329.0 5,215.6 1.2

Indexlinked bonds 0.0 0.0 0.0

Credit bonds and emerging marked bonds 2,843.3 2,431.2 -6.1

Loans etc. 5.1 131.4 5.2

Total bonds and loans 6,177.4 7,778.1 -1.1

Affiliated companies 0.0 0.0 0.0

Other financial investment assets 90.3 252.9 3.7

Derivative financial instruments for hedging the

net change of assets and liabilities 42.4 48.8

Return in % is weighted in time based on the current return.

Accounting value Return in %

p.a. before tax

Page 33: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

Årsrapport 2018

Tuborg Boulevard 3, 2900 Hellerup - CVR nr. 10 49 68 37

Pensionskassen for Farmakonomer

Godkendt på pensionskassens generalforsamling, den 24. april 2019

Dirigent

Page 34: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

2 Årsrapport 2018

Pensionskassen for Farmakonomer

Indholdsfortegnelse

Ledelsesberetning 3 Ledelsespåtegning 10 Den uafhængige revisors revisionspåtegning 11 Resultat- og totalindkomstopgørelse 15 Balance 16 Egenkapital og Kapitalgrundlag 18 Noter 19

Page 35: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

3 Årsrapport 2018

Pensionskassen for Farmakonomer

Ledelsesberetning

Pensionskassen for Farmakonomer driver pensionskassevirksomhed. Som medlemmer optager pensions-kassen farmakonomer, der er berettiget og forpligtet til medlemskab af pensionskassen gennem kollektiv overenskomst eller ansættelsesaftale. Herudover har bestyrelsen mulighed for at optage medlemmer, der er ansat i lignende stillinger og med en tilsvarende uddannelse.

Pensionskassen har organiseret sin virksomhed med investeringsaktiviteter i tilknyttede virksomheder. Det er imidlertid den samlede pensionskassekoncerns resultater, der har betydning for medlemmets pension. Hovedtallene i denne beretning er derfor præsenteret på koncernbasis medmindre andet fremgår specifikt.

Årets resultat Koncernens resultat for 2018 blev et underskud på 55,1 mio. kr. Underskuddet foreslås af bestyrelsen overført til næste år.

Medlemsbidrag, eksklusiv indskud, og pensionsydelser er steget. Pensionskassen er dog ikke i vækst, idet pensionsydelserne overstiger pensionsbidragene.

Det samlede afkast før pensionsafkastskat af pensionskassens aktiver blev -2,4 %.

Årets resultat vurderes at være acceptabelt, og pensionskassen er stadig velkonsolideret.

Året der gik

Økonomi Den globale økonomi fortsatte de gode takter i 2018 med en vækst på omkring 4 %. Væksten blev under-støttet af faldende arbejdsløshed i både USA og Europa. Samtidig steg inflationen og gav anledning til, at centralbankerne i USA og Europa kunne stramme pengepolitikken. I USA i form af 4 rentestigninger i 2018, mens den europæiske centralbank besluttede at stoppe med opkøb af obligationer efter december 2018.

Usikkerheden om hvordan stramningen af pengepolitikken og truslen om en global handelskrig vil påvirke den globale vækst gav anledning til faldende aktiemarkeder i både USA og Europa i 4. kvartal, hvor marke-derne faldt med hhv. 14 % og 12 %. For 2018 var der tale om fald på 6 % i USA og 14 % i Europa.

Faldene på aktiemarkederne lagde en dæmper på rentestigningerne, idet mange investorer søgte mod mere sikre investeringer som obligationer. I Europa er renterne stort set uforandrede i 2018, mens ameri-kanske 10- årige renter er steget med ca. 0,3 %. Det er lavere end de korte renter, som er steget med 1 % i forlængelse af den amerikanske centralbanks renteforhøjelser.

Kontorente Pensionskassens kontorente var 4,7 % før skat. Kontorenten er også i 2019 fastsat til 4,7 % før skat.

Investeringsporteføljen

Afkast Det samlede afkast i 2018 blev på -2,4 %, svarende til -254,7 mio. kr.

Obligationer og reale aktiver bidrog med positive afkast i 2018, men aktier, kredit og absolut afkast gav negative afkast.

Page 36: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

4 Årsrapport 2018

Pensionskassen for Farmakonomer

Investeringer og Samfundsansvar Pensionskassen har på baggrund af FN’s verdensmål og klimaaftalen fra Paris et signifikant fokus på at be-kæmpe klimaforandringer, udbrede grøn energi og fremme bæredygtighed. Verdensmålene agerer som pejlemærker for pensionskassens klimastrategi.

Retningslinjerne for ansvarlige investeringer følger principperne fremsat af FN’s Global Compact. I forbin-delse med FN’s Global Compact har pensionskassen vedtaget en yderligere politik for, at der ikke må inve-steres i kontroversielle våben, kulminer eller tobak. Endvidere har pensionskassen en skattepolitik.

Det aktive ejerskab udøves primært ved løbende at gå i dialog med de selskaber, der bliver investeret i for at sikre, at de overholder de retningslinjer, der er fremsat af pensionskassen. Dette har til formål at sikre selskabernes langsigtede værdiskabelse, hvorved der skabes størst mulige afkast til medlemmerne. Så-fremt et selskab ikke lever op til retningslinjerne, går pensionskassen i dialog med det pågældende sel-skab. I tilfælde af at der ikke er udsigt til, at selskabet vil forbedre sig på sigt, og forsætter med at agere i strid med pensionskassen, vil det resultere i, at selskabet bliver ekskluderet fra investeringsuniverset. De selskaber der bliver ekskluderet noteres, og offentliggøres på pensionskassen’s hjemmeside, hvor der også findes informationer omhandlende selskaber, der er under observation samt med hvilke, der er dialog.

Ud fra økonomiske og klimamæssige hensyn, besluttede pensionskassen i 2015, at trække investeringer ud af de første kulmineselskaber. Siden har pensionskassen indgået i dialog med en længere række selska-ber med aktiviteter indenfor kul. Dialogen har til formål, at reducere selskabernes aktiviteter indenfor kul og omdanne disse til mere klimavenlige energikilder. Dette har resulteret i, at pensionskassen har eksklu-deret 60 selskaber, og fortsat er i dialog med 7 selskaber.

Der er ligeledes fokus på olie- og gasselskaber, og i hvor høj grad deres forretningsmodel er i overens-stemmelse med klimamålet fremsat ved Paris aftalen. På samme grundlag som kulmineselskaber, er der blevet ekskluderet 63 olie- og gasselskaber, og fortsat dialog med 19 selskaber. Observationslisten vedli-geholdes løbende.

Mod slutningen af året blev der igangsat et fokus på transportsektoren, herunder primært bilsektoren. Der er igangsat en dialog med 15 selskaber, der tilsammen udgør 3/4 af pensionskassen’s samlede investerin-ger i bilsektoren. I starten af 2019 vil disse selskaber blive vurderet i forhold til den grønne omstilling, her-under Paris-aftalen.

Pensionskassen bruger også sit ejerskab til at fremme arbejdstagerrettigheder – også her med generalfor-samlinger som løftestang for at sikre ansvarlighed. Pensionskassen mener at selskaber, medarbejdere og investorer har fordel af at have ordentlige arbejds- og lønvilkår. Derfor arbejder pensionskassen på, at sel-skaberne får en bedre forståelse af, at investeringer i mennesker ved bl.a. ordentlige løn- og arbejdsvilkår bidrager til selskabernes langsigtede værdiskabelse. I 2018 var pensionskassen i dialog med 38 selskaber om deres arbejdstagerrettigheder.

Pensionskassen har – i samarbejde med de øvrige pensionskasser i PKA samarbejdet - et ambitiøst mål om, at 10 % af formuen, svarende til samlet set 30 mia. kr. skal være investeret i klimaprojekter ultimo 2020, mod samlet set 21 mia. kr. ved udgangen af 2018. I 2019 vil fokus derfor være på at foretage inve-steringer, der skaber værdi på flere niveauer. Det er selvfølgelig særligt klimainvesteringer, men der er også fokus på investeringer i udviklingslande, hvor Maj Invest står for at lancere selskabets tredje mikrofi-nansieringsfond og hvor pensionskassen har medvirket i de to foregående.

Samarbejde om investeringer og likvider Pensionskassens formue forvaltes af PKA A/S og pensionskassen samarbejder efter indgået aftale med an-dre pensionskasser administreret af PKA A/S om effektiv og rationel styring af investeringer og likvider for at opnå størst muligt afkast og minimering af omkostninger.

Afledte finansielle instrumenter Pensionskassen anvender afledte finansielle instrumenter til investerings- og afdækningsformål.

Page 37: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

5 Årsrapport 2018

Pensionskassen for Farmakonomer

Risici og solvens forbundet med pensionskassens forretningsmodel Pensionskassens forretningsmodel bygger på en overenskomstbaseret, kollektiv og solidarisk arbejdsmar-kedspensionsordning.

De væsentligste risici knytter sig til markedsrisici, forsikringsmæssige risici og outsourcing.

Markedsrisici Pensionskassen udbyder et gennemsnitsrenteprodukt. Nye medlemmer optages til en grundlagsrente på 0 %, ligesom pensionskassen har en mindre andel medlemmer med renter på 4,5 %. Dette medfører en eksponering mod renterisiko, som løbende afdækkes.

Pensionskassen ønsker at levere robuste pensioner til sine medlemmer. Dette sikres ved en langsigtet investeringsstrategi, hvor målet er at opnå høje, stabile afkast på en ansvarlig måde, der som minimum kan honorere afkastkravet fra de omregnede pensioner. Et vedvarende lavt afkast på investeringsakti-verne eller store finansielle tab er en risiko mod at kunne levere robuste pensioner. Den eksponering er pensionskassens markedsrisiko. Risikoen afdækkes ved at sprede investeringerne i en række forskellige aktivklasser.

Der investeres kollektivt for medlemmerne. Eventuelle tab på investeringerne dækkes af kollektivet, og andelen af bonuspotentialer i pensionskassen sikrer, at eventuelle tab på de finansielle markeder ikke overvæltes til medlemmernes depoter i de enkelte år, men at medlemmerne i stedet får tilskrevet den til enhver tid udmeldte kontorente – pt. 4,7 % før skat. Pensionskassen overvåger løbende risikoen for om-fordeling.

Risikotagning er en forudsætning for at opnå et tilstrækkeligt afkast til at sikre robuste pensioner. Det er i den sammenhæng en væsentlig opgave for bestyrelsen at få fastlagt den ønskede risikoappetit i form af den valgte investeringsstrategi.

Pensionskassens risikoappetit er fastsat ud fra to mål. Pensionskassen beskytter medlemmernes pensio-ner i Risikostyringsmodellen, og pensionskassen overholder gældende solvensregler (SCR). Bestyrelsen fastsætter i sin risikostyringspolitik sikkerhedsniveauerne for grænserne i Risikomodellen, der giver de risikomæssige rammer for pensionskassen i forhold til at beskytte pensionerne. I tillæg kan solvensdæk-ningen i særlige tilfælde sætte rammerne for pensionskassens risikotagning.

Pensionskassen har en kapitalplan og en nødplan baseret på Risikostyringsmodellen samt solvenskapital-kravet (SCR). I kapitalplanen skønnes den finansielle situation i pensionskassens strategiske planlæg-ningsperiode at være betryggende.

Forsikringsmæssige risici Pensionskassen giver livsvarige pensioner. Størstedelen af tilsagnene er givet på betinget grundlag, dvs. at pensionernes størrelse er bundet op på betingelser om bl.a. rente, levetid og risiko for invaliditet. Et betinget grundlag giver pensionskassen mulighed for at nedsætte parametrene i det tekniske grundlag, hvilket i så fald vil medføre nedsættelse af pensionerne.

Pensionskassen er en solidarisk ordning med invaliditetsdækning uden krav om helbredsoplysninger ved optagelse, så længe medlemmet er omfattet af en af de omfattede faggrupper.

Pensionskassen overvåger udviklingen i de forsikringsmæssige risici tæt, og hensætter i henhold til Fi-nanstilsynets levetidsbenchmark.

Outsourcing Pensionskassen anvender outsourcing i væsentligt omfang. Der er direkte outsourcing til PKA A/S, der igen har videreoutsourcet en stor del af driften til Forca A/S. Administration af ejendomme er outsourcet til DEAS A/S.

Risikoen styres i form af kontroller og serviceleveranceaftaler.

Page 38: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

6 Årsrapport 2018

Pensionskassen for Farmakonomer

Kapitalforhold Egenkapitalen er i 2018 reduceret med 55,1 mio. kr. til 1.245,7 mio. kr. Kapitalgrundlaget udgør herefter 1.652,3 mio. kr. mod 1.723,3 mio. kr. i 2017. Solvenskravet SCR er opgjort efter standardmodellen. Pr. 1. januar 2018 er SCR opgjort til 537,0 mio. kr. og udgør ultimo 2018 492,9 mio. kr. Nøgletallet Solvensdækning i % udarbejdes alene for pensionskassen og der udarbejdes ikke nøgletal for koncernen, da denne kun omfatter en pensionskasse. Solvensdækning i % for de sidste fem år er præsen-teret i nedenstående tabel 2014 2015 2016 2017 2018 Solvensdækning i % 482 514 326 321 335

Regnskabsbekendtgørelsen er ændret fra og med 2016. Det ikke fundet praktisk muligt at ændre tallene for perioden før 2016 således de bliver i overensstemmelse med den nye metode. Tallene for 2014-2015 er derfor ikke direkte sammenlignelige med 2016-2018. Pensionskassen har valgt, at anvende muligheden for at gengive følsomhedsoplysningerne i ledelsesbe-retningen, og ikke som en note i regnskabet fra og med årsrapporten 2018. Følsomhedsanalysen er præsenteret i pensionskassens Rapport om solvens og finansiel situation (SFCR) 2018, som er tilgængelig på hjemmesiden www.PKA.dk. Bonuspolitik Fastlæggelsen af satser sker ud fra en målsætning om at sikre en stabil udvikling over tid i medlemmernes pensioner. Bestyrelsen har fastsat kontorenten til 4,7 % for 2019. Kontorenten kan nedsættes, hvis den økonomiske situation kræver det. Øvrige satser fastsættes som udgangspunkt årligt. Egenkapitalen i pensionskassen ejes af medlemmerne. Resultatet i pensionskassen tilgår i sin helhed altid medlemmerne. Hensættelser til pensionsaftaler Hensættelser til pensionsaftaler består af elementerne Garanterede ydelser, Individuel bonuspotentiale, Kollektiv bonuspotentiale og Risikomargen. Hensættelserne til pensionsaftaler er i 2018 reduceret med 408,9 mio. kr. til 8.546,5 mio. kr. Usikkerhed ved indregning og måling Ved udarbejdelsen af årsrapporten foretages en række skøn og vurderinger om fremtidige forhold, som har indflydelse på den regnskabsmæssige værdi af aktiver og forpligtelser. De væsentligste områder omfatter de pensionsmæssige forpligtelser samt værdiansættelse af unoterede alternative investeringer. Ledelsen vurderer, at de anvendte forudsætninger er forsvarlige men forbundet med en vis usikkerhed. Regnskabsmæssige skøn er beskrevet nærmere i note 1 ”Anvendt regnskabspraksis”.

Page 39: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

7 Årsrapport 2018

Pensionskassen for Farmakonomer

Begivenheder efter balancedagen Der har ikke været begivenheder efter statusdagen, som har væsentlig indflydelse på pensionskassens og koncernens økonomiske forhold. Forventninger til fremtiden Den globale økonomi udviser fortsat ikke nævneværdige svaghedstegn, arbejdsløsheden er lav i både USA og Europa, ligesom inflationen med et niveau på omkring 2 % er på et tilfredsstillende niveau. På det se-neste har økonomiske indikatorer i USA og Europa udvist en faldende tendens formentlig på baggrund af truslen om en global handelskrig. Det er endnu for tidligt at sige, om det er tegn på en langvarig svæk-kelse af økonomien. Indtil der kommer mere klarhed om den økonomiske udvikling, må det forventes, at de finansielle marke-der forbliver nervøse, og yderligere fald i renter og aktier kan ikke udelukkes i løbet af 2019. Usikkerheden om den globale vækst vil også påvirke takten i den amerikanske centralbanks renteforhøjel-ser, som forventes at blive færre end de 4, der blev foretaget i 2018. I Europa er der ikke forventning om renteforhøjelser før tidligst i 4. kvartal pga. usikkerhed om den økonomiske udvikling. Pensionskassen er robust og står godt rustet i forhold til disse udfordringer. Administration Pensionskassen og de tilknyttede virksomheder administreres af PKA A/S. PKA A/S har outsourcet en del af sine administrative opgaver blandt andet til Forca A/S og DEAS mfl. Direktionen og den ansvarshavende aktuar er ansat men ikke aflønnet af pensionskassen. Pensionskassekoncernen Pensionskassens tilknyttede (100 % ejede) virksomheder pr. 31. december 2018 fremgår af koncernover-sigten.

Pensionskassen for Farmakonomer

Farmakonomers Ejendomsaktieselskab

FarmaPension A/S

Pensionskassens ejendomsaktieselskab Selskabet har til formål at eje og drive fast ejendom med henblik på at opnå langsigtet forrentning af den investerede kapital. Selskabets resultat for 2018 udgør et overskud på 2,4 mio. kr. FarmaPension A/S Selskabet er uden aktivitet. Selskabet har indsendt anmodning om tibagebetaling af uberettiget opkrævet moms for tidligere periode. SKAT har endu ikke startet sagsbehandling. Resultatet for 2018 er 0,0 mio. kr. Revisionsudvalg I henhold til lovgivningen skal pensionskassen etablere et revisionsudvalg. Formanden skal være uaf-hængig og mindst et medlem skal have kvalifikationer indenfor regnskabsvæsen eller revision. Formanden for revisionsudvalget er Susanne Kure, som opfylder kravene om både uafhængighed og kva-lifikationer inden for regnskabsvæsen eller revision. Det øvrige medlem af revisionsudvalget er Susanne Engstrøm.

Page 40: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

8 Årsrapport 2018

Pensionskassen for Farmakonomer

Status for opfyldelse af måltal for det underrepræsenterede køn i ledelsen Der er i lov om finansiel virksomhed krav om, at finansielle virksomheder skal opstille måltal for den køns-mæssige repræsentation i bestyrelsen samt udarbejde en politik for ligerepræsentation i ledelsen af sel-skabet, hvis der er en underrepræsentation af det ene køn i bestyrelsen. Der er underrepræsentation, hvis det ene køn er repræsenteret med mindre end 40 % i bestyrelsen. Reglerne om måltal for kønsrepræsentation i bestyrelsen tager udgangspunkt i de generalforsamlings-valgte medlemmer af bestyrelsen, men i pensionskassen udpeges et flertal af bestyrelsesmedlemmerne af overenskomstparterne. Det bliver på den baggrund ikke retvisende at vedtage måltal for de generalfor-samlingsvalgte medlemmer af bestyrelsen. Bestyrelsen har derfor fastsat et måltal for den kønsmæssige sammensætning af den samlede bestyrelse. Bestyrelsen har besluttet, at måltallet for mænd i bestyrelsen skal være mindst 25 % og måltallet for kvin-der i bestyrelsen skal være mindst 40 %. Ved årets udgang var den kønsmæssige andel i bestyrelsen så-dan, at der var 37,5 % mænd i bestyrelsen og 62,5 % kvinder i bestyrelsen. De opstillede måltal er således opfyldt. Der er ikke vedtaget en politik for ligerepræsentation i ledelseslagene under direktionen i pensionskas-sen. Pensionskassen totaladministreres af PKA A/S. PKA A/S havde i 2018 en fordeling mellem kønnene på 57 % mænd og 43 % kvinder i ledelseslagene under direktionen. Pr. 1. december 2018 skiftede køns-fordelingen til 64 % mænd og 36 % kvinder, og der vil i løbet af 2019 blive udarbejdet en politik for lige-repræsentation i ledelseslagene under direktionen i PKA A/S.

Page 41: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

9 Årsrapport 2018

Pensionskassen for Farmakonomer

Ledelseshverv Direktionens ledelseshverv er følgende: Administrerende direktør Peter Damgaard Jensen Adm. direktør i PKA A/S Adm. direktør i PKA+ Pension Forsikringsselskab A/S Adm. direktør i fire pensionskasser administreret af PKA A/S Adm. direktør i Sygeplejerskernes og Lægesekretærernes Ejendomsaktieselskab Adm. Direktør i Sundhedsfagliges Ejendomsaktieselskab Adm. direktør i Socialrådgivernes, Socialpædagogernes og Kontorpersonalets Ejendomsaktieselskab Direktør i PKA Private Funds GP ApS Direktør i PKA Ejendomme af 2012 I/S Bestyrelsesformand i A/S Kjøbenhavns Ejendomsselskab Bestyrelsesformand i Forstædernes Ejendomsaktieselskab Bestyrelsesformand i Institutional Holding P/S Bestyrelsesformand i PKA AIP A/S Bestyrelsesformand i PKA Private Funds P/S Bestyrelsesformand i Poppelstykket 12 A/S Bestyrelsesformand i PKA Skejby Komplementar ApS Bestyrelsesformand i PKA Skejby P/S Bestyrelsesformand i Farmapension A/S Næstformand i Forca A/S Bestyrelsesmedlem i AIP Management P/S Bestyrelsesmedlem i Valified ApS Bestyrelsesmedlem i Forsikringsorganisationernes Fællessekretariat F.M.B.A. Bestyrelsens ledelseshverv er følgende: Bestyrelsesformand Henrik Klitmøller Rasmussen Bestyrelsesformand i Gemeinschaft A/S Bestyrelsesmedlem i MP Pension – Pensionskassen for Magistre og Psykologer Bestyrelsesmedlem i MP Ejendomme P/S Bestyrelsesmedlem i MP Investment Management A/S Næstformand Christina Nicolajsen Durinck Bestyrelsesmedlem i Pensionskassernes Administration A/S Bestyrelsesmedlem Jørgen Moestrup Bestyrelsesmedlem i A-Dosispak Komplementar ApS Bestyrelsesmedlem Danish Pharma Care A/S Bestyrelsesmedlem i A-Apotekets Dosispak P/S Bestyrelsesmedlem i Apotekernes A.M.B.A Bestyrelsesmedlem i Danmarks Apotekerforenings Jubilæumsfond Bestyrelsesmedlem Jesper Gulev Larsen Bestyrelsesformand i Pharmakon A/S Bestyrelsesmedlem i D.A. Invest og Udvikling A/S Bestyrelsesmedlem Susanne Kure, formand for revisionsudvalget Bestyrelsesmedlem og revisionsudvalgsformand i PKA+ Pension Forsikringsselskab A/S Bestyrelsesmedlem og medlem i revisionsudvalget i Pensionskassen for Socialrådgivere, Socialpædagoger og Kontorpersonale Bestyrelsesmedlem i Investeringsselskabet af 24. februar 2015 A/S Bestyrelsesmedlem i Genan Holding A/S Bestyrelsesmedlem i Changegroup Holding A/S og 1 af selskabets 100 % ejede datterselskaber Bestyrelsesmedlem Susanne Engstrøm, medlem revisionsudvalg Øvrige bestyrelsesmedlemmer har ingen yderligere ledelseshverv

Page 42: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

10

Årsrapport 2018

Ledelsespåtegning

Vi har dags dato behandlet og godkendt årsrapporten for regnskabsåret 1. januar - 31. december 2018 for Pensionskassen for Farmakonomer.

Årsrapporten aflægges i overensstemmelse �ed lov om finansiel virksomhed.

Det er vores opfattelse, at koncernregnskabet og årsregnskabet giver et retvisend� billede af koncernens og pensionskassens aktiver og passiver og finansielle stilling pr. 31. december 2018 og resultatet af kon­cernens og pensionskassens aktiviteter for regnskabsåret 1. januar - 31. december 2018.

Ledelsesberetningen indeholder efter vores opfattelse et retvisende billede for udviklingen i koncernens og pensionskassens aktiviteter og økonomiske forhold, årets resultater og koncernens og pensionskassens fi­nansielle stilling samt en beskrivelse af væsentlige risici og usikkerhedsfaktorer, som koncernen henholds­vis pensionskassen står over for.

Årsrapporten indstilles til generalforsamlingens godkendelse.

Hellerup, den 11. marts 2019

Bestyrelsen:

Henrll<litmøller Rasmussen Formand

Pensionskassen for Farmakonomer

Susanne Kure

, I

Page 43: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

11 Årsrapport 2018

Pensionskassen for Farmakonomer

Den uafhængige revisors revisionspåtegning Til medlemmerne i Pensionskassen for Farmakonomer Konklusion Det er vores opfattelse, at koncernregnskabet og årsregnskabet giver et retvisende billede af koncernens og pensionskassens aktiver, passiver og finansielle stilling pr. 31. december 2018 samt af resultatet af koncernens og pensionskassens aktiviteter for regnskabsåret 1. januar – 31. december 2018 i overens-stemmelse med lov om finansiel virksomhed. Vores konklusion er konsistent med vores revisionsprotokollat til revisionsudvalget og bestyrelsen. Hvad har vi revideret Pensionskassen for Farmakonomers koncernregnskab og årsregnskab for regnskabsåret 1. januar – 31. december 2018 omfatter resultat- og totalindkomstopgørelse, balance, egenkapital og kapitalgrundlag, samt noter, herunder anvendt regnskabspraksis (’regnskabet’) Grundlag for konklusion Vi udførte vores revision i overensstemmelse med internationale standarder om revision (ISA) og de yder-ligere krav, der er gældende i Danmark. Vores ansvar ifølge disse standarder og krav er nærmere beskre-vet i revisionspåtegningens afsnit Revisors ansvar for revisionen af regnskabet. Det er vores opfattelse, at det opnåede revisionsbevis er tilstrækkeligt og egnet som grundlag for vores konklusion. Uafhængighed Vi er uafhængige af koncernen i overensstemmelse med internationale etiske regler for revisorer (IESBA’s Etiske regler) og de yderligere krav, der er gældende i Danmark, ligesom vi har opfyldt vores øvrige etiske forpligtelser i overensstemmelse med IESBA’s Etiske regler. Efter vores bedste overbevisning er der ikke udført forbudte ikke-revisionsydelser som omhandlet i artikel 5, stk. 1, i forordning (EU) nr. 537/2014. Valg Vi blev første gang valgt som revisor for Pensionskassen for Farmakonomer ved generalforsamlingen den 17. april 2018 for regnskabsåret 2018. Centrale forhold ved revisionen Centrale forhold ved revisionen er de forhold, der efter vores faglige vurdering var mest betydelige ved vo-res revision af regnskabet for 2018. Disse forhold blev behandlet som led i vores revision af regnskabet som helhed og udformningen af vores konklusion herom. Vi afgiver ikke nogen særskilt konklusion om disse forhold. Centralt forhold ved revisionen Hvordan vi har behandlet det centrale forhold

ved revisionen Måling af unoterede investeringer Unoterede investeringer omfatter både investerin-ger foretaget indirekte via fonde og ved direkte ejerskab. Investeringerne er primært foretaget i gearede lån, katastrofeforsikringer samt erhvervs- og boligejendomme. Der er i mindre omfang foreta-get investeringer i skov & landbrug samt private equity. Investeringerne indgår i regnskabsposterne Inve-steringsejendomme, Investeringer i tilknyttede og associerede virksomheder og Andre finansielle inve-steringsaktiver. Direkte ejede unoterede investeringer måles til en skønnet dagsværdi, der primært er baseret på vær-diansættelsesmodeller og forudsætninger herunder

Måling af unoterede investeringer Vi gennemgik og vurderede forretningsgange og in-terne kontroller for måling af unoterede investerin-ger. Vi vurderede og testede de af ledelsen anvendte værdiansættelsesmodeller. Vi testede stikprøvevis sammenhængen mellem de anvendte forudsætninger og beregningen af dags-værdier. Herunder foretog vi test af priser rappor-teret af eksterne managers, samt intern opfølgning på priser og markedsudvikling. Vi udfordrede de ledelsesmæssige skøn, der ligger til grund for beregning af dagsværdier ud fra vores kendskab til porteføljen og markedsudviklingen.

Page 44: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

12 Årsrapport 2018

Pensionskassen for Farmakonomer

ledelsesmæssige skøn, der ikke er observerbare for tredjemand. Unoterede investeringer ejet indirekte igennem fonde- og foreninger forvaltet eksternt, måles til en skønnet dagsværdi baseret på rapporteringer fra investeringsforvaltere, supplerende oplysning om prisudviklingen, samt analyser af værdiansættel-serne. Vi fokuserede på måling af unoterede investeringer, fordi opgørelsen er kompleks og involverer betyde-lige ledelsesmæssige skøn. Der henvises til koncern- og årsregnskabets omtale af ’Regnskabsmæssige skøn’ i note 1, ’Investerings-ejendomme’ i note 8, ’Kapitalandele i associerede virksomheder’ i note 15 samt ’Andre finansielle in-vesteringsaktiver’ i note 9

Måling af hensættelser til pensionsaftaler og inve-steringskontrakter Pensionskassen har hensættelser til pensionsaftaler og investeringskontrakter for i alt 8.547 mio. kr., hvilket udgør 77,4% af den samlede balance Hensættelserne består primært af pensionshensæt-telser til garanterede ydelser, individuelt bonuspo-tentiale og risikomargen. Opgørelsen er baseret på aktuarmæssige principper og involverer væsentlige regnskabsmæssige skøn knyttet til de aktuarmæssige forudsætninger om den tidsmæssige placering og omfang af de fremti-dige betalinger til forsikringstagerne. De aktuarmæssige forudsætninger omfatter væ-sentligst rentekurve til tilbagediskontering, leveti-der, dødelighed, invaliditet, tilbagekøbssandsynlig-hed og omkostninger. Vi fokuserede på måling af hensættelser til pensi-onsaftaler og investeringskontrakter, fordi opgørel-sen af hensættelserne er kompleks og involverer betydelige regnskabsmæssige skøn. Der henvises til koncern- og årsregnskabets omtale af ’Regnskabsmæssige skøn’ i note 1, samt ’Pensi-onshensættelser’ i note 13.

Måling af hensættelser til pensionsaftaler og inve-steringskontrakter Vi gennemgik og vurderede de af pensionskassen tilrettelagte forretningsgange og interne kontroller, der er etableret for at sikre, at hensættelser til pen-sionsaftaler og investeringskontrakter måles kor-rekt. I forbindelse med revisionen anvendte vi vores egne aktuarer til at vurdere de af pensionskassen anvendte aktuarmæssige modeller og forudsætnin-ger samt de foretagne beregninger, herunder opgø-relser af de fremtidige betalingsstrømme. Vi vurderede og udfordrede de væsentligste aktu-armæssige forudsætninger såsom rentekurve til til-bagediskontering, levetider, dødelighed, invaliditet, tilbagekøbssandsynlighed samt omkostninger ud fra vores erfaring og branchekendskab med henblik på at vurdere, om disse er i overensstemmelse med markedspraksis samt regulatoriske og regnskabs-mæssige krav. Dette omfattede en vurdering af kontinuiteten i grundlaget for opgørelsen af hen-sættelser.

Page 45: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

13 Årsrapport 2018

Pensionskassen for Farmakonomer

Udtalelse om ledelsesberetningen Ledelsen er ansvarlig for ledelsesberetningen.

Vores konklusion om regnskabet omfatter ikke ledelsesberetningen, og vi udtrykker ingen form for konklu-sion med sikkerhed om ledelsesberetningen.

I tilknytning til vores revision af regnskabet er det vores ansvar at læse ledelsesberetningen og i den for-bindelse overveje, om ledelsesberetningen er væsentligt inkonsistent med regnskabet eller vores viden op-nået ved revisionen eller på anden måde synes at indeholde væsentlig fejlinformation.

Vores ansvar er derudover at overveje, om ledelsesberetningen indeholder krævede oplysninger i henhold til lov om finansiel virksomhed.

Baseret på det udførte arbejde er det vores opfattelse, at ledelsesberetningen er i overensstemmelse med koncernregnskabet og årsregnskabet og er udarbejdet i overensstemmelse med kravene i lov om finansiel virksomhed. Vi har ikke fundet væsentlig fejlinformation i ledelsesberetningen.

Ledelsens ansvar for regnskabet Ledelsen har ansvaret for udarbejdelsen af et koncernregnskab og et årsregnskab, der giver et retvisende billede i overensstemmelse med lov om finansiel virksomhed. Ledelsen har endvidere ansvaret for den interne kontrol, som ledelsen anser for nødvendig for at udarbejde et regnskab uden væsentlig fejlinfor-mation, uanset om denne skyldes besvigelser eller fejl.

Ved udarbejdelsen af regnskabet er ledelsen ansvarlig for at vurdere koncernens og pensionskassens evne til at fortsætte driften; at oplyse om forhold vedrørende fortsat drift, hvor dette er relevant; samt at udarbejde regnskabet på grundlag af regnskabsprincippet om fortsat drift, medmindre ledelsen enten har til hensigt at likvidere koncernen eller pensionskassen, indstille driften eller ikke har andet realistisk alter-nativ end at gøre dette.

Revisors ansvar for revisionen af koncernregnskabet og årsregnskabet Vores mål er at opnå høj grad af sikkerhed for, om regnskabet som helhed er uden væsentlig fejlinforma-tion, uanset om dette skyldes besvigelser eller fejl, og at afgive en revisionspåtegning med en konklusion. Høj grad af sikkerhed er et højt niveau af sikkerhed, men er ikke en garanti for, at en revision, der udføres i overensstemmelse med ISA og de yderligere krav, der er gældende i Danmark, altid vil afdække væsent-lig fejlinformation, når sådan findes. Fejlinformationer kan opstå som følge af besvigelser eller fejl og kan betragtes som væsentlige, hvis det med rimelighed kan forventes, at de enkeltvis eller samlet har indfly-delse på de økonomiske beslutninger, som brugerne træffer på grundlag af regnskabet.

Som led i en revision, der udføres i overensstemmelse med ISA og de yderligere krav, der er gældende i Danmark, foretager vi faglige vurderinger og opretholder professionel skepsis under revisionen. Herud-over:

• Identificerer og vurderer vi risikoen for væsentlig fejlinformation i regnskabet, uanset om denne skyldesbesvigelser eller fejl, udformer og udfører revisionshandlinger som reaktion på disse risici samt opnårrevisionsbevis, der er tilstrækkeligt og egnet til at danne grundlag for vores konklusion. Risikoen for ikkeat opdage væsentlig fejlinformation forårsaget af besvigelser er højere end ved væsentlig fejlinformationforårsaget af fejl, idet besvigelser kan opfatte sammensværgelser, dokumentfalsk, bevidste udeladelser,vildledning eller tilsidesættelse af intern kontrol.

• Opnår vi forståelse af den interne kontrol med relevans for revisionen for at kunne udforme revisions-handlinger, der er passende efter omstændighederne, men ikke for at kunne udtrykke en konklusion omeffektiviteten af koncernens og selskabets interne kontrol.

• Tager vi stilling til, om den regnskabspraksis, som er anvendt af ledelsen, er passende, samt om deregnskabsmæssige skøn og tilknyttede oplysninger, som ledelsen har udarbejdet er rimelige.

• Konkluderer vi, om ledelsens udarbejdelse af regnskabet på grundlag af regnskabsprincippet om fortsatdrift er passende, samt om der på grundlag af det opnåede revisionsbevis er væsentlig usikkerhed for-bundet med begivenheder eller forhold, der kan skabe betydelig tvivl om koncernens og pensionskassensevne til at fortsætte driften. Hvis vi konkluderer, at der er en væsentlig usikkerhed, skal vi i voresrevisionspåtegning gøre opmærksom på oplysninger herom i regnskabet eller, hvis sådanne oplysningerikke er tilstrækkelige, modificere vores konklusion. Vores konklusioner er baseret på det revisionsbevis,der er opnået frem til datoen for vores revisionspåtegning. Fremtidige begivenheder eller forhold kandog medføre, at koncernen eller pensionskassen ikke længere kan fortsætte driften.

• Tager vi stilling til den samlede præsentation, struktur og indhold af koncernregnskabet og årsregnska-bet, herunder noteoplysningerne, samt om regnskabet afspejler de underliggende transaktioner og be-givenheder på en sådan måde, at der gives et retvisende billede heraf.

• Opnår vi tilstrækkeligt og egnet revisionsbevis for de finansielle oplysninger i virksomhederne eller for-retningsaktiviteterne i koncernen til brug for at udtrykke en konklusion om koncernregnskabet. Vi er

Page 46: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

/I 14

Årsrapport 2018

/

ansvarlige for at lede, føre tilsyn og udføre koncernrevisionen. Vi er eneansvarlige for vores revisions­konklusion.

Vi kommunikerer med den øverste ledelse om bl.a. det planlagte omfang og den tidsmæssige placering af revisionen samt betydelige revisionsmæssige observationer, herunder eventuelle betydelige mangler i in-tern kontrol, som vi identificerer under revisionen. /

\

Vi afgiver også en udtalelse til den øverste ledelse om, at vi har opfyldt relevante etiske krav vedrørende uafhængighed, og oplyser den om alle relationer og andre forhold, der med rimelighed kan tænkes at på­virke vores uafhængighed og, hvor dette er relevant, tilhørende sikkerhedsforanstaltninger.

Med udgangspunkt i de forhold, der er kommunikeret til den øverste ledelse, fastslår vi, hvilke forhold der var mest betydelige ved revisionen af regnskabet for den aktuelle periode og dermed er centrale forhold ved revisionen. Vi beskriver disse forhold i vores revisionspåtegning, medmindre lov eller øvrig regulering udelukker, at forholdet offentliggøres, eller i de yderste tilfælde, hvor vi fastslår, at forholdet ikke skal kommunikeres i vores revisionspåtegning, fordi de negative konsekvenser heraf med rimelighed ville kunne forventes at veje tungere end de fordele, den offentlige interesse har af sådan kommunikation.

København, den 11. marts 2019

PricewaterhouseCoopers

Statsautoriseret Revisionspartnerselskab CVR-nr. 33 77 12 31

Christian Fredensborg Jakobsen Statsautoriseret revisor mne16539

a)LPer Rolf Larssen Statsautoriseret revisor mne24822

Pensionskassen for Farmakonomer

Page 47: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

15 Årsrapport 2018

Pensionskassen for Farmakonomer

Resultat- og totalindkomstopgørelse

Alle beløb i mio. kr. Pensionskassen Koncernen Note 2018 2017 2018 2017 Bruttomedlemsbidrag 3 199,5 195,1 199,5 195,1 Medlemsbidrag f.e.r., i alt 199,5 195,1 199,5 195,1 Indtægter fra tilknyttede virksomheder 2,4 -1,0 Indtægter fra associerede virksomheder 37,5 17,4 37,5 17,4Indtægter af investeringsejendomme 0,1 0,1 2,5 -0,9Renteindtægter og udbytter m.v. 61,6 127,0 61,6 127,0Kursreguleringer 4 -107,3 608,4 -107,3 608,4Renteudgifter -239,1 -0,7 -239,1 -0,7Administrationsomkostninger i forbindelse med investeringsvirksomhed -9,9 -44,9 -9,9 -44,9 Investeringsafkast, i alt -254,7 706,4 -254,7 706,4 Pensionsafkastskat 41,9 -101,3 41,9 -101,3 Udbetalte ydelser -463,3 -418,0 -463,3 -418,0 Pensionsydelser f.e.r., i alt -463,3 -418,0 -463,3 -418,0 Ændring i pensionshensættelser f.e.r. i alt 5 408,9 -88,8 408,9 -88,8 Ændring i fortjenstmargen 0,0 0,0 0,0 0,0

Ændring i overskudskapital 15,9 0,0 15,9 0,0 Administrationsomkostninger -3,3 -9,2 -3,3 -9,2 Pensionsmæssige driftsomkostninger f.e.r. i alt 6 -3,3 -9,2 -3,3 -9,2 Overført investeringsafkast 66,1 -130,3 66,1 -130,3 PENSIONSTEKNISK RESULTAT 11,0 153,9 11,0 153,9 Egenkapitalens investeringsafkast -80,3 99,5 -80,3 99,5 RESULTAT FØR SKAT -69,2 253,4 -69,2 253,4 Pensionsafkastskat for egenkapital 14,2 30,8 14,2 30,8 ÅRETS RESULTAT -55,1 284,2 -55,1 284,2 ANDEN TOTALINDKOMST 0,0 0,0 0,0 0,0

ÅRETS TOTALINDKOMST -55,1 284,2 -55,1 284,2 Realiseret resultat 7 Årets resultat overføres til egenkapitalen.

Page 48: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

16 Årsrapport 2018

Pensionskassen for Farmakonomer

Balance

AKTIVERAlle beløb i mio. kr. Pensionskassen Koncernen

Note 2018 2017 2018 2017

Investeringsejendomme 8 3,6 3,6 3,6 43,6

Kapitalandele i tilknyttede virksomheder 15 43,4 41,0Kapitalandele i associerede virksomheder 15 250,8 213,3 250,8 213,3 Investeringer i tilknyttede og associerede virksomheder, i alt 294,1 254,2 250,8 213,3

Kapitalandele 83,1 8,3 83,1 8,3Investeringsforeningsandele 4.656,6 10.378,9 4.656,6 10.378,9Obligationer 5.253,5 0,0 5.253,5 0,0Andre udlån 270,8 5,1 270,8 5,1Indlån i kreditinstitutter 93,2 90,3 93,2 90,3Afledte finansielle instrumenter 89,7 0,0 89,7 0,0 Andre finansielle investeringsaktiver, i alt 9 10.446,9 10.482,6 10.446,9 10.482,6 INVESTERINGSAKTIVER I ALT 10.744,6 10.740,5 10.701,3 10.739,5

Tilgodehavender hos pensionstagere 0,0 0,4 0,0 0,4Tilgodehavender hos tilknyttede virksomheder 0,1 0,0Andre tilgodehavender 0,0 23,5 0,1 23,5 TILGODEHAVENDER, I ALT 0,1 23,9 0,1 23,9

Udskudte skatteaktiver 207,0 90,3 207,0 90,3Likvide beholdninger 0,1 0,0 44,0 1,3 ANDRE AKTIVER, I ALT 207,1 90,3 251,1 91,6

Tilgodehavende renter 29,5 0,0 29,5 0,0Andre periodeafgrænsningsposter 55,3 36,0 55,3 36,0 PERIODEAFGRÆNSNINGSPOSTER, I ALT 84,8 36,0 84,8 36,0

AKTIVER I ALT 11.036,6 10.890,6 11.037,3 10.890,9

Sikkerhedsstillelse 10

Eventualaktiv 11

Page 49: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

17 Årsrapport 2018

Pensionskassen for Farmakonomer

Balance

PASSIVER Alle beløb i mio. kr. Pensionskassen Koncernen Note 2018 2017 2018 2017 Overført overskud 1.245,7 1.300,8 1.245,7 1.300,8 EGENKAPITAL, I ALT 1.245,7 1.300,8 1.245,7 1.300,8 Overskudskapital 12 406,6 422,5 406,6 422,5 ANSVARLIG LÅNEKAPITAL I ALT 406,6 422,5 406,6 422,5 Pensionshensættelser 13 8.546,5 8.955,3 8.546,5 8.955,3Fortjenstmargen på pensionshensættelser 0,0 0,0 0,0 0,0

8.546,5 8.955,3 8.546,5 8.955,3 Gæld vedrørende afledte finansielle instrumenter 9 176,6 0,0 176,6 0,0Gæld til kreditinstitutter 558,8 0,0 558,8 0,0Aktuelle skatteforpligtelser 71,6 148,8 71,6 148,8Anden gæld 30,0 46,8 30,7 47,2 GÆLD, I ALT 837,1 195,6 837,7 196,0 PERIODEAFGRÆNSNINGSPOSTER 0,7 16,2 0,7 16,2 PASSIVER I ALT 11.036,6 10.890,6 11.037,3 10.890,9 Anvendt regnskabspraksis 1 Femårsoversigt over hoved- og nøgletal 2

Eventualforpligtelser 14 Nærtstående parter m.v. 15 Risikooplysninger 16 Specifikation af aktiver og disses afkast 17

HENSÆTTELSER TIL PENSIONSAFTALER OG INVESTERINGSKONTRAKTER, I ALT

Page 50: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

18 Årsrapport 2018

Pensionskassen for Farmakonomer

Egenkapital og Kapitalgrundlag

Alle beløb i mio. kr. Pensionskassen Koncernen

Egenkapital 2018 2017 2018 2017 Egenkapital pr. 1. januar 1.300,8 1.439,2 1.300,8 1.439,2Overført til overskudskapital -422,5 -422,5Overført fra disponering af årets resultat -55,1 284,2 -55,1 284,2Anden totalindkomst 0,0 0,0 0,0 0,0 Egenkapital i alt 1.245,7 1.300,8 1.245,7 1.300,8

Pensionskassen KoncernenKapitalgrundlag 2018 2017 2018 2017 Egenkapital 1.245,7 1.300,8 1.245,7 1.300,8Overskudskapital 406,6 422,5 406,6 422,5 Kapitalgrundlag i alt 1.652,3 1.723,3 1.652,3 1.723,3

Page 51: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

19 Årsrapport 2018

Pensionskassen for Farmakonomer

Noter Alle beløb i mio. kr. Note 1 Anvendt regnskabspraksis Årsrapporten for koncernen og pensionskassen er udarbejdet i overensstemmelse med bestemmelserne i Lov om finansiel virksomhed og Finanstilsynets Regnskabsbekendtgørelse om finansielle rapporter for for-sikringsselskaber og tværgående pensionskasser. Anvendt regnskabspraksis er uændret i forhold til 2017. Der er foretaget mindre reklassifikationer i resultatopgørelse og balance. Årsrapporten præsenteres i millioner kroner med en decimal. Hvert tal afrundes hver for sig. Der kan der-for forekomme afvigelser mellem de anførte totaler og summen af de underliggende tal. Principper for fordeling af over- og underskud Pensionskassen har i overensstemmelse med bekendtgørelse om kontributionsprincippet anmeldt princip for fordeling af årets realiserede resultat til Finanstilsynet. Hovedprincippet er, at den del af årets realiserede resultat, der tilfalder egenkapitalen og overskudskapital, består af en forrentning svarende til investeringsafkastet før PAL-skat tillagt risikoforrentning på 0,5 % for de ubetingede garanterede bestand og 0,2 % for de betingede garanterede bestand, af de gennemsnitlige pensionshensættelser. Betalinger til og fra egenkapitalen fragår i egenkapitalens andel af det realiserede resultat. Tab, der dækkes af egenkapitalen og overskudskapital, kan hentes i det efterfølgende regnskabsår fra de kollektive bonuspotentialer, hvis det er muligt. Andelene der overføres fra de kollektive bonuspotentialer i det efterfølgende regnskabsår anmeldes til Finanstilsynet. Koncernregnskabet Koncernregnskabet omfatter pensionskassen og tilknyttede virksomheder, hvor der udøves bestemmende indflydelse. Koncernregnskabet udarbejdes ved sammenlægning (konsolidering) af pensionskassens og de tilknyttede virksomheders regnskabsposter med ensartet indhold. Ved konsolidering foretages eliminering af koncerninterne indtægter og omkostninger samt koncerninterne aktiebesiddelser og mellemværender. Koncerninterne ydelser afregnes på markedsbaserede vilkår eller på omkostningsdækkende basis. Kon-cerninterne handler med værdipapirer og andre investeringsaktiver afregnes til markedsværdier. Omregning af valuta Transaktioner i udenlandsk valuta omregnes til transaktionsdagens valutakurs. Balanceposter i udenlandsk valuta omregnes til balancedagens lukkekurs. Alle valutagevinster og -tab indregnes i resultatopgørelsen under valutakursregulering. Generelle principper for indregning og måling Aktiver indregnes i balancen, når det er sandsynligt, at fremtidige fordele vil tilfalde virksomheden, og aktivets værdi kan måles pålideligt. Forpligtelser indregnes i balancen, når det er sandsynligt, at fremti-dige økonomiske fordele vil fragå virksomheden, og forpligtelsen kan måles pålideligt. I resultatopgørelsen indregnes alle indtægter i takt med, at de indtjenes, og alle omkostninger indregnes med de beløb, der vedrører regnskabsåret. Køb og salg af finansielle instrumenter indregnes på afviklingsdagen, og indregningen ophører, når retten til at modtage/afgive pengestrømme fra det finansielle aktiv eller passiv er udløbet, eller hvis det er over-draget. Købs- eller salgstransaktioner, som på balancedagen endnu ikke er afviklet, indgår i resultatop-gørelsen med deres tab eller avance. Ved første indregning måles finansielle instrumenter til dagsværdi. Måling efter første indregning sker som beskrevet for hver enkelt regnskabspost nedenfor.

Page 52: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

20 Årsrapport 2018

Pensionskassen for Farmakonomer

Regnskabsmæssige skøn samt usikkerhed ved indregning og måling Opgørelsen af den regnskabsmæssige værdi af visse aktiver og forpligtelser opgøres på baggrund af me-toder med antagelser, der medfører brug af regnskabsmæssige skøn. Disse skøn foretages af ledelsen i overensstemmelse med regnskabspraksis og på baggrund af historiske erfaringer samt forudsætninger, som ledelsen anser som forsvarlige og realistiske. Som følge af skønnenes natur kan de anvendte forudsætninger vise sig at være ufuldstændige, ligesom uventede fremtidige begivenheder eller omstændigheder kan opstå. Herunder vil andre kunne komme frem til andre skøn. De væsentligste skøn, som ledelsen foretager i forbindelse med opgørelse af den regnskabsmæssige værdi af visse aktiver og forpligtelser, og den væsentlige skønsmæssige usikkerhed forbundet med udar-bejdelsen af årsregnskabet, er de samme som ved udarbejdelsen af årsregnskabet året før. De områder, der især er forbundet med skøn, er måling af dagsværdi af unoterede finansielle instrumenter samt for-pligtelser vedrørende pensionsmæssige hensættelser. Skønnene knytter sig især til de forudsætninger, der ligger til grund for rapportering, der modtages fra eksterne investeringsforvaltere, samt den tidsmæssige forskydning, der er fra opgørelse til indregning i regnskabet. Måling af dagsværdi af infrastrukturaktiver Værdiansættelsen af infrastrukturaktiver bygger på nutidsværdien af det fremtidige cash flow i planlæg-ningsperioden fremregnet i interne modeller. Den lange planlægningsperiode, op til 25 år ved investerin-gens start, forøger usikkerheden om det forventede cash flow. De væsentligske skøn knytter sig til dis-konteringsrenten, samt specifikke elementer for de enkelte investeringer, fx udvikling i el-priser, produk-tion, vedligeholdelsesomkostninger samt omkostninger til bortskaffelse ved udløb af produktionsperioden. Måling af dagsværdi af investeringsejendomme Fastlæggelse af dagsværdien af investeringsejendomme er forbundet med væsentlige skøn. Skønnet knytter sig især til fastlæggelsen af forrentningskrav. Måling af dagsværdi af øvrige unoterede finansielle instrumenter Pensionskassen har unoterede investeringer, hvor der ikke findes et aktivt marked. De unoterede inve-steringer dækker bl.a over direkte investeringer i unoterede aktier, unoterede lån samt skov og landbrug gennem fonde Opgørelserne er baseret på modeller og i videst muligt omfang på observerbare data, og værdiansættelserne er påvirket af skøn. Måling af pensionsmæssige hensættelser Fastlæggelse af den regnskabsmæssige værdi af de pensionsmæssige hensættelser er forbundet med skøn, der især knytter sig til diskonteringsrentekurven og forudsætningerne om dødelighed. Forudsætnin-gerne om bedste skøn for invaliditet er baseret på den observerede invaliditet i de senere år. Fastlæg-gelse af forudsætningerne er påvirket af aktuarmæssige skøn, der har betydning for hensættelsernes størrelse. Resultatopgørelsen Bruttomedlemsbidrag Bruttomedlemsbidrag i pensionskassen omfatter forfaldne medlemsbidrag for januar – november og for-ventede medlemsbidrag for december. Medlemsbidrag er reduceret med arbejdsmarkedsbidrag. Investeringsafkast Indtægter fra tilknyttede og associerede virksomheder indeholder pensionskassens andel af virksomheder-nes driftsresultater efter skat. Indtægter af investeringsejendomme indeholder resultat af ejendomsdrift før regulering af ejendommenes værdi. I resultatet fragår omkostninger til ejendomsadministration. Renter og udbytter m.v. indeholder regnskabsårets indtjente renter og modtagne udbytter m.v. vedrø-rende investeringsaktiver. Kursregulering indeholder realiserede og urealiserede gevinster på investeringsaktiver herunder værdire-gulering af investeringsejendomme.

Page 53: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

21 Årsrapport 2018

Pensionskassen for Farmakonomer

Pensionsafkastskat Pensionsafkastskat indregnes i resultatopgørelsen med et beløb, der er beregnet på grundlag af regnskabs-årets skattepligtige afkast. Pensionsafkastskatten, som hviler på det afkast, der først indregnes i pensions-kassens skattegrundlag i et efterfølgende regnskabsår, er indregnet som udskudt pensionsafkastskat. Pensionsafkastskat fordeles mellem egenkapitalen og medlemmerne. Egenkapitalens andel af pensionsaf-kastskat beregnes på baggrund af egenkapitalens andel af realiseret resultat. Udbetalte ydelser Pensionsydelser omfatter ekspederede og udbetalte pensioner. Administration Pensionskassen betaler et årligt fast beløb (tarif) pr. medlem til PKA A/S for de aftalte administrative ydel-ser, hvori indgår lønninger og vederlag til direktion og bestyrelse. Pensionskassen og de tilknyttede virksomheder betaler herudover en fast promillesats af formuens dags-værdi for porteføljepleje. Tarif og promillesats er fastsat på markedsbaserede vilkår. Omkostninger ved værdipapiradministration er indregnet som administrationsomkostninger i forbindelse med investeringsvirksomhed. Omkostninger ved ejendomsadministration er fradraget i indtægter af investeringsejendomme. Overført investeringsafkast Overført investeringsafkast er beregnet på grundlag af egenkapitalens andel af det realiserede resultat og indregnes i posten Egenkapitalens investeringsafkast. Balancen Aktiver Investeringsejendomme Investeringsejendomme måles til dagsværdi på balancedagen. Investering i skov måles til skønnet dagsværdi med udgangspunkt i mægleropgørele og skønnet dagsværdi af beregnet træmængde. Fritidsbolig i udlandet måles til anskaffelsesværdi. Kapitalandele i tilknyttede virksomheder Kapitalandele i tilknyttede virksomheder måles til indre værdi (equity-metoden). Efter denne metode bliver de tilknyttede virksomheders driftsresultater indregnet i pensionskassens resultatopgørelse. Pensionskas-sens resultat og egenkapital er herefter identiske med koncernens. Regnskabsresultaterne fra de tilknyttede virksomheder fremkommer ved anvendelse af indregnings- og målingsmetoder, der er identiske med de principper, der er anvendt i pensionskassen. Kapitalandele i associerede virksomheder Kapitalandele i associerede virksomheder indregnes med pensionskassens ejerandel af virksomhedernes regnskabsmæssige indre værdi. Virksomhedernes indre værdi fremkommer ved anvendelse af målingsme-toder, der er identiske med de metoder, der er anvendt i pensionskassen. Alle reguleringer indregnes i ind-tægter fra associerede virksomheder. Som associerede virksomheder betragtes virksomheder, som ikke er tilknyttede virksomheder, men hvori koncernens virksomheder har andele på mere end 20 % af stemmerettighederne, og hvor der udøves be-tydelig indflydelse på virksomhedernes driftsmæssige og finansielle ledelse gennem repræsentation i virk-somhedernes bestyrelser. Associerede virksomheder med negativ regnskabsmæssig indre værdi måles til nul, og et eventuelt tilgo-dehavende hos disse virksomheder nedskrives med moderselskabets andel af den negative indre værdi, i

Page 54: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

22 Årsrapport 2018

Pensionskassen for Farmakonomer

det omfang det vurderes uerholdeligt. Såfremt den regnskabsmæssige negative indre værdi overstiger til-godehavendet, indregnes det resterende beløb under hensatte forpligtelser, i det omfang modervirksomhe-den har en retlig eller faktisk forpligtelse til at dække den pågældende virksomheds forpligtelser. Kapitalandele Børsnoterede kapitalandele måles til dagsværdi baseret på børsnoterede lukkekurser på balancedagen. Unoterede kapitalandele måles til dagsværdi baseret på en individuel vurdering af virksomhederne, med henblik på at fastsætte den pris, som kapitalandelene skønnes at kunne handles til. Værdiansættelsen er i høj grad baseret på oplysninger fra eksterne kapitalforvaltere. Pensionskassen har etableret interne processer, der skal understøtte de udarbejdede skøn. Der tages så-ledes højde for tidsmæssige forskydninger mellem rapportering og regnskabsdata ved at indhente sup-plerende oplysning om prisudviklingen. Derudover foretages der analyser af værdiansættelserne i forhold til eksterne modparter og i forhold til pri-ser fastsat af en uafhængig finansiel institution for at vurdere og efterprøve de fastsatte værdier Investeringsforeningsandele Investeringsforeningsandele måles til dagsværdi baseret på børsnoterede lukkekurser på balancedagen. Obligationer Fastforrentede obligationer, konvertible obligationer og indeksobligationer med tillæg af indeksreguleringer måles til dagsværdi baseret på børsnoterede lukkekurser på balancedagen. Dagsværdien af udtrukne obli-gationer baseres på obligationernes nutidsværdi, der tilnærmelsesvis udgør obligationernes nominelle værdi. Andre udlån Direkte ejendomskredit måles til dagsværdi, hvilket som udgangspunkt er kurs pari. Værdiansættelsen kontrolleres i forhold til aktuelle spreads i markedet, låntagers kreditværdighed samt det bagvedliggende kollateral. Øvrig direkte kredit måles med udgangspunkt i ekstern værdiansættelse og kontrolleres i forhold til udvik-lingen i lignende kreditrisiko for både noterede og unoterede værdipapirer i markedet. Afledte finansielle instrumenter Afledte finansielle instrumenter, anvendt til renterisikoafdækning og andre formål, måles til dagsværdi. In-strumenter med positiv dagsværdi indregnes som aktiver under Afledte finansielle instrumenter og instru-menter med negativ dagsværdi indregnes under Gæld vedrørende afledte finansielle instrumenter. Repo/reverse Værdipapirer, der er solgt som led i salgs- og tilbagekøbsforretninger, beholdes i balancen under den re-spektive hovedpost f.eks. ”obligationer” som forrentes og kursreguleres. Det modtagne beløb indregnes og forrentes som gæld til modparten. Værdipapirer erhvervet som led i købs- og tilbagesalgsforretninger op-tages som tilgodehavender hos modparten og afkastet indregnes under renter. Øvrige poster i aktiverne Tilgodehavender optages til pålydende værdi med fradrag af nedskrivning for forventede tab. Passiver Egenkapital Pensionskassens egenkapital tilhører medlemmerne kollektivt. Overskudskapital Overskudskapital indgår i basiskapitalen på lige fod med egenkapitalen, men tilfalder over tid de forsikrede og er dermed en del af hensættelsen til forsikringskontrakter. Hensættelser til pensionsaftaler og investeringskontrakter Hensættelser til pensionsaftaler og investeringskontrakter opgøres af pensionskassens ansvarshavende ak-tuar.

Page 55: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

23 Årsrapport 2018

Pensionskassen for Farmakonomer

Selskabet overgik pr. 30.09.2018 fra at anvende EIOPAS basis diskonteringsrentekurve til at anvende EIOPAS diskonteringsrentekurve med VA-tillæg, til brug for opgørelse af hensættelserne. Renterne på ren-tekurven med VA-tillæg er ikke ændret meget i forhold til ultimo 2017. Isoleret set har ændringerne vedrø-rende rentekurven medført et fald på 20 mio. kr. i den akkumulerede værdiregulering.

Pensionshensættelserne består af elementerne Garanterede ydelser, Individuelt bonuspotentiale, Kollektivt bonuspotentiale og Risikomargen.

Pensionshensættelsers element Garanterede ydelser opgøres ved, for hver forsikring, at opgøre markeds-værdien af de forventede garanterede betalingsstrømme. Markedsværdien beregnes ved at diskontere de enkelte betalinger med den af den europæiske tilsynsmyndighed EIOPA opgjorte rente med VA-tillæg, re-duceret med pensionsafkastskat. Garanterede ydelser indeholder et skønnet beløb til dækning af fremti-dige forsikringsydelser, som stammer fra forsikringsbegivenheder indtruffet i regnskabsåret, men som endnu ikke var anmeldt på balancedagen.

Individuelt bonuspotentiale indeholder værdien af forpligtelser til at yde bonus på baggrund af den enkelte bonusberettigede forsikrings depot.

Kollektivt bonuspotentiale indeholder forsikringsbestandens andel af realiserede resultater, som er hensat kollektivt til de bonusberettigede forsikringer. Beløbet er endnu ikke tilskrevet det enkelte medlem.

Risikomargen indeholder det beløb, som pensionskassen forventeligt vil skulle betale en anden forsik-ringsvirksomhed for, at denne vil overtage risikoen for at afvikle bestanden. Risikomargen indhentes så vidt muligt af forsikringernes individuelle dernæst kollektive bonuspotentiale – eller subsidiært kapital-grundlaget. Risikomargen opgøres i henhold til Solvens II-reglerne. Pensionskassen har pr. 1. januar 2018 ændret opgørelsesmetoden af risikomargen og anvender fra og med regnskabsåret 2018 mulighe-den for at bruge tabsabsorberende buffere. Ændringen er behandlet som ændring i regnskabsmæssigt skøn, og har isoleret set reduceret risikomargen med 98 mio. kr.

Forudsætningerne om bedste skøn for dødelighed er baseret på Finanstilsynets benchmark for den aktuelle dødelighed, der tilpasses pensionskassens specifikke forhold vedrørende forsikringsbestandens observe-rede dødelighed. I tillæg hertil indregnes Finanstilsynets benchmark for forventede levetidsforbedringer. Finanstilsynets benchmarks opdateres årligt, og pensionskassen gennemfører årligt en analyse af eventu-elle afvigelser fra benchmark for den aktuelle dødelighed.

Forudsætningerne om bedste skøn for invaliditet er baseret på den observerede invaliditet i de senere år.

Diskonteringsrentekurven og forudsætningerne om dødelighed er de forudsætninger, der har størst effekt på målingen af hensættelserne.

Fortjenstmargen Fortjenstmargen angiver nutidsværdien af pensionskassens endnu ikke indtjente fortjeneste på forsikrin-gerne, som forventes indregnet i resultatopgørelsen med tiden. Fortjenstmargen udskilles af pensions-hensættelserne.

Øvrige poster i passiverne Gæld måles til amortiseret kostpris, der sædvanligvis svarer til nominel værdi.

Eventualforpligtelser Tilsagn om investeringer, afgivne garantier og kautioner mv. uden for forsikringsforhold er anført i en note til årsrapporten.

Nøgletal Nøgletal udarbejdes efter reglerne i Finanstilsynets Regnskabsbekendtgørelse om finansielle rapporter for forsikringsselskaber og tværgående pensionskasser.

Page 56: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

24 Årsrapport 2018

Pensionskassen for Farmakonomer

Note 2Femårsoversigt over hoved- og nøgletal

Pensionskassen 2014 2015 2016 2017 2018Medlemsbidrag 194 192 198 195 200 Pensionsydelser * -502 -366 -407 -418 -463Investeringsafkast 774 195 552 706 -255Pensionsmæssige driftsomkostninger, i alt -7 -8 -8 -9 -3Resultat af afgiven forretning 0 0 0 0 0Pensionsteknisk resultat 293 -195 87 154 11 Årets resultat 351 -114 151 284 -55Hensættelser til pensionsaftaler i alt * 8.441 8.591 8.867 8.955 8.546 Egenkapital, i alt 1.517 1.380 1.439 1.301 1.246 Aktiver, i alt 10.127 10.067 10.415 10.891 11.037

Koncernen 2014 2015 2016 2017 2018Medlemsbidrag 194 192 198 195 200 Pensionsydelser -502 -366 -407 -418 -463Investeringsafkast 775 195 552 706 -255Pensionsmæssige driftsomkostninger, i alt -11 -10 -8 -9 -3Resultat af afgiven forretning 0 0 0 0 0Pensionsteknisk resultat 293 -195 87 154 11 Årets resultat 351 -114 151 284 -55Hensættelser til pensionsaftaler i alt * 8.441 8.591 8.867 8.955 8.546 Egenkapital, i alt 1.517 1.380 1.439 1.301 1.246 Aktiver, i alt 10.132 10.069 10.416 10.891 11.037

Nøgletal ** 2014 2015 2016 2017 2018Afkast relateret til gennemsnitsrenteprodukter * % 9,7 2,3 6,6 6,9 -2,4Omkostninger af hensættelser * % 0,1 0,1 0,1 0,1 0,0Omkostninger pr. medlem kr. 968 1.027 1.044 1.162 411Egenkapitalforrentning efter skat % 25,9 -7,9 10,7 21,2 -4,3Forrentning af overskudskapital, der tildeles afkast som egenkapital % - - - - -2,1

* Regnskabsbekendtgørelsen er ændret fra og med 2016. Med henvisning til bekendtgørelsens § 84,stk. 2 er det ikke fundet praktisk muligt at ændre femårsoversigten, således at tallene for perioden før 2016 bliver i overensstemmelse med den nye metode. Tallene for 2014-2015 er derfor ikke direktesammenlignelige med 2016-2018.

** Nøgletal her angives for Pensionskassen, og der udarbejdes ikke nøgletal for koncern, da denne kun omfatter én pensionskasse.

Page 57: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

25 Årsrapport 2018

Pensionskassen for Farmakonomer

Note 3 Pensionskassen KoncernenBruttomedlemsbidrag 2018 2017 2018 2017

Direkte forsikring med bonusordningMedlemsbidrag 194,2 192,1 194,2 192,1Medlemsindskud 5,4 3,0 5,4 3,0

Bruttomedlemsbidrag i alt 199,5 195,1 199,5 195,1

PensionsaftalerTegnet i ansættelsesforhold 199,5 195,1 199,5 195,1

Præmier fordelt på landeDanmark 198,0 195,1 198,0 195,1Andre EU-lande 1,3 0,0 1,3 0,0Øvrige lande 0,2 0,0 0,2 0,0

Opgørelse af antal forsikredeTegnet i ansættelsesforhold 8.132 7.990 8.132 7.990

Note 4 Pensionskassen KoncernenKursreguleringer 2018 2017 2018 2017

Kapitalandele -3,1 -39,2 -3,1 -39,2Investeringsforeningsandele -72,9 288,9 -72,9 288,9Obligationer 114,4 356,6 114,4 356,6Andre udlån 3,7 2,3 3,7 2,3Afledte finansielle instrumenter -122,6 0,0 -122,6 0,0Likvide beholdninger -26,7 -0,2 -26,7 -0,2

Kursreguleringer i alt -107,3 608,4 -107,3 608,4

Note 5 Pensionskassen KoncernenÆndring i pensionshensættelser f.e.r. i alt 2018 2017 2018 2017

Individuel bonuspotentiale 157,2 151,0 157,2 151,0Garanterede ydelser -460,3 -56,5 -460,3 -56,5Risikomargen -105,8 -5,7 -105,8 -5,7

Ændring i pensionshensættelser f.e.r. i alt -408,9 88,8 -408,9 88,8

Samtlige bidrag er direkte forsikring med ret til bonus.

Pensionskassens samlede antal forsikrede medlemmer er opgjort incl. medlemskaber, hvorfra der kun udbetales børnepensioner.

Page 58: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

26 Årsrapport 2018

Pensionskassen for Farmakonomer

Note 6 Pensionskassen KoncernenPensionsmæssige driftsomkostninger f.e.r. 2018 2017 2018 2017

261,7 290,0 261,7 290,0126,3 100,0 126,3 100,0

Susanne Engstrøm 75,3 50,0 75,3 50,054,1 50,0 54,1 50,054,1 50,0 54,1 50,054,1 50,0 54,1 50,0

38,3 38,3126,3 126,3

130,0 130,0

790,2 720,0 790,2 720,0

Løn

Pensionskassen Koncernen2018 2017 2018 2017

0,0 6.925,0 0,0 6.925,00,0 527,0 0,0 527,00,0 43,0 0,0 43,0

0,0 7.495,0 0,0 7.495,0

Revisor

Pensionskassen Koncernen2018 2017 2018 2017

Revisor (beløb i tusinde kr.)Lovpligtig revision af årsregnskabet 254,0 412,0 254,0 412,0Andre erklæringsopgaver med sikkerhed 91,5 75,0 91,5 75,0

Samlede revisoromkostninger 345,5 487,0 345,5 487,0

Nærmere oplysninger om aflønning i administrationsfællesskabet PKA kan ses på pka.dk.

Christina Nicolajsen Durick

Ann-Mari Damholt Grønbæk (indtrådt 17.04.2018)Susanne Kure (indtrådt 01.01.2018)Bjarne Fabienke (udtrådt 31.12.2017)

Der er ingen ansatte i pensionskassen ud over direktionen og den ansvarshavende aktuar.

Honorar til bestyrelsen (beløb i tusinde kr.)Henrik Klitmøller Rasmussen

Samlede lønninger

Lønsumsafgift m.m.

Revisors arbejde sker i stort omfang fælles for de af PKA A/S administrerede pensionskasser.

Lisa Wieweg Rosendahl Hermansen

PensionsbidragLønninger

Jesper Gulev LarsenJørgen Moestrup

Lønninger (beløb i tusinde kr.)

Direktionen og den ansvarshavende aktuar er ikke aflønnet af pensionskassen.

Administrerende direktør Peter Damgaard Jensen har modtaget et samlet vederlag for alle sine funktioner fra administrationsselskabet PKA A/S på i alt 4.355 t. kr.

Samlet honorar til bestyrelsen

Pensionskassens andel af revisoromkostningerne inklusive moms udgør:

Page 59: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

27 Årsrapport 2018

Pensionskassen for Farmakonomer

Note 7 Pensionskassen KoncernenRealiseret resultat 2018 2017 2018 2017

-274,0 728,1 -274,0 728,1-4,2 -25,2 -4,2 -25,217,0 6,3 17,0 6,3

Markedsværdiregulering 65,4 29,0 65,4 29,0

Realiseret resultat i alt -195,8 738,0 -195,8 738,0

som er fordelt til:Tilskrivning af bonus 345,3 352,6 345,3 352,6

-26,2 132,1 -26,2 132,1Forrentning til overskudskapital -8,7 0,0 -8,7 0,0Pensionsafkastskat vedrørende overskudskapital -1,6 0,0 -1,6 0,0Overført til egenkapitalen 21,1 284,2 21,1 284,2

-14,2 -30,8 -14,2 -30,8-511,6 0,0 -511,6 0,0

Fordelt i alt -195,8 738,0 -195,8 738,0

Bevægelser på egenkapitalen:Fra realiseret resultat 21,1 284,2 21,1 284,2

-76,2 0,0 -76,2 0,0

Årets resultat -55,1 284,2 -55,1 284,2

Tilgodehavende egenkapitalforrentning:Manglende forrentning primo 113,3 240,7 113,3 240,7

-35,8 -127,4 -35,8 -127,4

77,5 113,3 77,5 113,3

Note 8 Pensionskassen KoncernenInvesteringsejendomme 2018 2017 2018 2017

Dagsværdi pr. 1. januar 3,6 3,6 43,6 48,0Afgang i året 0,0 0,0 -40,0 -3,3Årets værdiregulering til dagsværdi 0,0 0,0 0,0 -1,1

Dagsværdi i alt 3,6 3,6 3,6 43,6

Principperne for deling af det realiserede resultat samt beregning af risikotillæg er beskrevet i anvendt regnskabspraksis.

RenteresultatRisikoresultat

Overført til hensættelser

Pensionsafkastskat vedrørende egenkapitalen

Omkostningsresultat

Pensionsafkastskat

Tilgodehavende egenkapitalforrentning

Ændring i individuel bonuspotentiale

Nedskrivning

Page 60: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

28 Årsrapport 2018

Pensionskassen for Farmakonomer

Note 9Andre finansielle investeringsaktiver

Pensionskassens formue forvaltes af PKA A/S.

Finansielle instrumenter (Pensionskassen og Koncernen)

Afledte finansielle instrumenter 2018 År til udløb HovedstolBogført værdi

Swaps 0-1 1.950,0 34,8Swaps 1-10 1.862,5 -7,5Swaps +10 50,6 -1,8Valutaterminsforretninger 0-1 10.135,9 -112,5

Note 10 Pensionskassen KoncernenSikkerhedsstillelse 2018 2017 2018 2017

401,7 0,0 401,7 0,0

560,4 0,0 560,4 0,0

Note 11Eventualaktiv

I pensionskassens investeringspolitik tages der hensyn til en række sociale, miljømæssige og etiske forhold. Pensionskassen investerer ikke i virksomheder, der overlagt og konsekvent overtræder national lovgivning eller regler fastsat af internationale organisationer tiltrådt af Danmark. Endvidere investerer pensionskassen ikke i kontroversielle våben, kulminer eller tobak.

For afledte finansielle instrumenter knytter væsentlige betingelser sig til udviklingen i renter, aktiekurser og valuta.

For øvrige finansielle instrumenter, såsom obligationer, kapitalandele mv., er der ingen specielle væsentlige betingelser eller vilkår, som influerer på de fremtidige betalingsstrømme.

På www.pka.dk kan ses en løbende opdateret liste over de virksomheder, som pensionskassen har kapitalandele i.

Pensionskassen har til sikkerhed for opfyldelsen af forpligtelser ved afdækning af rente- og aktiekursricisi netto deponeret obligationer til en værdi af

Den bogførte værdi af afledte finansielle instrumenter i balancen sker brutto. Summen af alle kontrakter med positiv værdi føres i aktiverne under posten ”Afledte finansielle instrumenter”. Summen af alle kontrakter med negativ værdi føres i passiverne under posten ”Gæld vedrørende afledte finansielle instrumenter”.

Sikkerhedsstillelse for repo forretninger

I 2014 blev dansk momspraksis ændret, hvorefter der ikke skal betales moms for visse ydelser til pensionskasser.

Pensionskassen har indsendt anmodning om tilbagebetaling af uberettiget opkrævet moms til SKAT, og anmodninger afventer sagsbehandling. Det er uklart i hvilket omfang Pensionskassen vil opnå tilbagebetaling og dermed størrelsen af det forventede samlede tilgodehavende.

Page 61: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

29 Årsrapport 2018

Pensionskassen for Farmakonomer

Note 12 Pensionskassen KoncernenOverskudskapital 2018 2017 2018 2017

Overskudskapital primo 422,5 - 422,5 -Indbetalinger 10,4 - 10,4 -Udbetalinger -17,7 - -17,7 -Andel af realiseret resultat efter pensionsafkastskat -8,7 - -8,7 -Overført fra Egenkapital 422,5 422,5

Overskudskapital i alt 406,6 422,5 406,6 422,5

Note 13 Pensionskassen KoncernenPensionshensættelser 2018 2017 2018 2017

Pensionshensættelser primo 8.955,3 8.866,6 8.955,3 8.866,6Fortjenstmargen primo 0,0 0,0 0,0 0,0 Pensionsmæssige hensættelser i alt primo 8.955,3 8.866,6 8.955,3 8.866,6Kollektiv bonuspotentiale primo 0,0 0,0 0,0 0,0Akkumuleret værdiregulering primo -272,9 -301,9 -272,9 -301,9 Retrospektive hensættelser primo 8.682,4 8.564,7 8.682,4 8.564,7Primo korrektion 19,4 19,4Bruttobidrag 199,5 196,8 199,5 196,8Rentetilskrivning 342,7 279,8 342,7 279,8Pensionsydelser -463,3 -411,7 -463,3 -411,7

-3,9 0,0 -3,9 0,07,3 12,8 7,3 12,8

51,3 51,1 51,3 51,17,3 0,0 7,3 0,02,4 -11,1 2,4 -11,1

8.845,2 8.682,4 8.845,2 8.682,4212,9 272,9 212,9 272,9

Kollektiv bonuspotentiale ultimo 0,0 0,0 0,0 0,0 Pensionsmæssige hensættelser i alt ultimo 9.058,1 8.955,3 9.058,1 8.955,3

-511,6 0,0 -511,6 0,00,0 0,0 0,0 0,0

Pensionshensættelser i alt 8.546,5 8.955,3 8.546,5 8.955,3

Individuelt KollektivtGaranterede bonus- bonus- ydelser potentiale potentiale I alt

Pensionshensættelser pr. 1. januar 2018Opgørelsesrente 0,0% 5.959,3 2.218,2 0,0 8.177,5Opgørelsesrente 4,5% 577,5 0,6 0,0 578,0

Alle grupper 6.536,8 2.218,8 0,0 8.755,6

Risikomargen alle grupper 199,8

Pensionshensættelser i alt 8.955,3

Overført til/fra medlemskapital

Akkumuleret værdiregulering ultimoRetrospektive hensættelser ultimo

Fortjenstmargen ultimo

Pensionskassens forsikringer er omfattet af kontributionsprincippet. Pensionskassen har imidlertid vedtaget andre principper for fordeling af det realiserede resultat end, hvad der følger af kontributionsbekendtgørelsen (BEK nr. 1643 af 14. december 2016). Bekendtgørelsens bestemmelser følges i det omfang, de ikke strider imod pensionskassens principper. I praksis vil det sige, at pensionskassen ikke anvender en gruppeopdeling efter bekendtgørelsens § 3.

Risikogevinst efter tilskrivning af risikobonus Egenkapitalfinansierede ydelser

Omkostningstillæg efter tilskrivning af omkostningsbonus

Andet

Anvendt individuel bonuspotentiale

Fordeling af hensættelser på oprindelig grundlagsrente for bestande, der ikke er omfattet af kontributionsprincippet:

Page 62: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

30 Årsrapport 2018

Pensionskassen for Farmakonomer

Individuelt KollektivtGaranterede bonus- bonus-

ydelser potentiale potentiale I alt

Pensionshensættelser pr. 31. december 2018Opgørelsesrente 0,0% 5.529,1 2.375,4 0,0 7.904,5Opgørelsesrente 4,5% 547,4 0,6 0,0 548,0

Alle grupper 6.076,5 2.376,0 0,0 8.452,5

Risikomargen alle grupper 93,9

Pensionshensættelser i alt 8.546,5

2018 2017 2018 2017Afkast-procent

Afkast-procent

Bonus-grad

Bonus-grad

Opgørelsesrente 0,0% -2,4% 6,9% 28,0% 26,6%Opgørelsesrente 4,5% -2,4% 6,9% 0,2% 0,2%

2018 2017

Gennemsnitrente -2,0% 5,0%

Note 14 Pensionskassen KoncernenEventualforpligtelser 2018 2017 2018 2017

Investeringsejendomme 3,6 0,0 3,6 0,0Kapitalandele i tilknyttede virksomheder 0,5 0,0 0,5 0,0Kapitalandele i associerede virksomheder 250,8 0,0 250,8 0,0Kapitalandele 42,0 0,0 42,0 0,0Investeringsforeningsandele 4.438,0 9.720,1 4.438,0 9.720,1Obligationer 4.390,8 0,0 4.390,8 0,0Andele i kollektive investeringer 76,7 0,0 76,7 0,0Andre udlån 77,3 0,0 77,3 0,0Indlån i kreditinstitutter 94,2 84,3 94,2 84,3Tilgodehavende renter 25,0 0,0 25,0 0,0

Til sikkerhed for hensættelser i alt 9.398,8 9.804,4 9.398,8 9.804,4

Investeringsaktiver til overtagelse efter regnskabsåret 0,0 0,0 0,0 0,0

Unoterede aktier 129,7 6,4 129,7 6,4Ejendomme 42,6 0,0 42,6 0,0Infrastruktur 26,0 0,0 26,0 0,0Kredit 104,0 0,0 104,0 0,0

302,3 6,4 302,3 6,4

Note 13 fortsat

Til sikkerhed for forsikredes hensættelser er registreret følgende aktiver:

Tilsagn om investeringer fratrukket allerede indbetalte beløb:

Forrentning af kundemidler efter omkostninger før skat opdelt på produkt:

Afkastprocent og Bonusgrad for de forsikringsbestande, der ikke er omfattet af kontributionspricippet:

Page 63: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

31 Årsrapport 2018

Pensionskassen for Farmakonomer

Note 14 fortsat

North Sea Infrastructure

Blafa

ZionPKA overtog i oktober 2018 49% af to solcelleparker i Californien. Begge solparker var fuldt udbygget og i drift på overtagelsestidspunktet. Pensionskassen har garanteret sin pro rata andel af visse drifts- og nedtagningsmæssige forpligtelser overfor Nordea Bank. Garantiforpligtelsen beløber sig pr. statusdagen til 0,8 mio. USD.

I oktober 2018 indgik Pensionskassen en aftale med Vattenfall og Vestas om opførelsen af en 353 MW onshore vindmøllepark i Sverige nær Umeå. Pensionskassens garantiforpligtelse pr. statusdagen udgøres af resterende pro rata andel af det samlede investeringstilsagn samt yderligere driftsmæssige garantier på i alt 28,7 mio. DKK.

Pensionskassen har sammen med Borgland Advisory AS investeret i Nyhamna gasbehandlingsanlæg i juli 2018. Aktivet er placeret i den nordvestlige del af Norge og udgør en central del af gasinfrastrukturen i Norge, hvorfra gassen fra den Norske kontinentalsokkel eksporteres til Storbritannien og kontinental Europa. Som led i den samlede finansiering er der udstedt et aktionærlån, hvoraf restforpligtelsen pr. statusdagen var 1,5 mio. NOK. Restforpligtelsen forventes dog ikke at blive kaldt, idet investeringen er fuldt finansieret pr. statusdagen.

Note 15Nærtstående parter m.v.

Pensionskassen har kapitalandele i følgende tilknyttede virksomheder: Aktivitet Hjemsted

Ejer-andel Resultat

Egen-kapital

Farmakonomernes Ejendomsaktieselskab

Investering i grunde og bygninger

Gentofte 100,0% 2,4 42,8

Farmapension A/S Administration København 100,0% 0,0 0,5

Pensionskassen har kapitalandele i følgende associerede virksomheder: Aktivitet Hjemsted

Ejer-andel Resultat

Egen-kapital

DEAS Invest I Holding A/S Ejendomsadministration Frederiksberg 33,3% 43,8 630,6

Page 64: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

32 Årsrapport 2018

Pensionskassen for Farmakonomer

Note 16Risikooplysninger

Der knytter sig en række risici til pensionskassens forretningsmodel.

• Livsforsikringsrisici• Markedsrisici, herunder renterisici• Outsourcingrisiko

Pensionskassen anvender outsourcing, hvilket giver anledning til fokus på de risici, der følger med. Risikoen er, at der opstår tab som følge af mangelfulde aftaler eller kontrol. Pensionskassen har indgået outsourcingaftale med PKA A/S om fuldstændig administration. Bestyrelsen har fastlagt politik og retningslinjer for outsourcing af væsentlige aktivitetsområder. Heri fastlægges reglerne for yderligere outsourcing til tredjepart. Det sikrer en tilfredsstillende opfølgning på de respektive underleverandører som f.eks. Forca A/S.

Bestyrelsen har i forbindelse med arbejdet med risiko og solvens identificeret de væsentligste risici, der knytter sig til forretningsmodellen:

Inden for livsforsikringsrisici er de biometriske risici, der omfatter levetidsforbedringer og ændringer i antallet af førtidspensionister, de væsentligste risici. Pensionskassen justerer løbende, med udgangspunkt i Finanstilsynets levetidsregime, sine forudsætninger om forventet levetid hos medlemmerne. Pensionskassens tilsagn er primært givet med betinget garanti, dvs. at pensionskassen har muligheden for at nedsætte parametrene i det tekniske grundlag for at sikre pensionskassens solvens ved uventet udvikling af forudsætningerne i grundlaget. I så fald nedsættes grundpensionerne.

Markedsrisici er defineret som risikoen for, at markedsværdien af aktiver og passiver ændres som følge af ændringer i markedsforholdene. De væsentligste markedsrisici findes inden for renter, aktier, valuta og reale aktiver samt ved investeringer i alternative afkastkilder. Pensionskassen styrer risiciene ved at sikre den nødvendige spredning af investeringerne. Bestyrelsen har i investeringsstrategien fastsat risikorammer for de forskellige aktivklasser.

Pensionskassen afdækker renterisiko på de garanterede ydelser ud fra bestyrelsens vedtagne ramme for renterisiko. Konsekvensen ved renteafdækningen er, at en væsentlig del af renterisikoen mellem passiver og aktiver er elimineret. En vigtig del af aktiverne til renteafdækning er renteswaps, hvor pensionskassen betaler en variabel rente og modtager en fast rente. Disse instrumenter har samme egenskab som de garanterede ydelser på den måde, at de stiger i værdi, hvis renten falder og omvendt.

Note 17Specifikation aktiver og disses afkast

Primo UltimoGrunde og bygninger 44,0 46,4 5,5 Noterede kapitalandele 4.161,1 1.942,9 -2,1Unoterede kapitalandele 225,2 499,0 9,4 Kapitalandele i alt 4.386,3 2.441,8 0,5 Stats- og realkreditobligationer 3.329,0 5.215,6 1,2 Indeksobligationer 0,0 0,0 0,0 Kreditobligationer og emerging markets obligationer 2.843,3 2.431,2 -6,1Udlån m.v. 5,1 131,4 5,2 Obligationer og udlån i alt 6.177,4 7.778,1 -1,1Dattervirksomheder 0,0 0,0 0,0 Øvrige investeringsaktiver 90,3 252,9 3,7

Afledte finansielle instrumenter til sikring af nettoændringen af aktiver og forpligtelser 42,4 48,8

Afkast i % er tidsvægtet på baggrund af afkastet på dagsbasis.

Regnskabsmæssig værdi Afkast i % p.a. før skat

Page 65: The Pharmaconomists’ Pension Fund - din pension PKA · The Pension Fund offers an average interest rate product. New members are admitted at a base interest rate of 0 per cent,

JBJ Dokument1 19.06.19 11:53 1 1